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ABSTRACT 
The human body harbours a diverse microbiota, which may have beneficial or 
detrimental effects on health. Bacteria can protect the body against viral infection or 
predispose the host to it. In addition, viruses and bacteria may induce cancer 
development, either alone or synergistically. The interactions between the 
indigenous bacteria and viruses remain poorly characterised.  
This thesis focused on the composition of the bacterial microbiota in the oral 
mucosa, cervix, placenta and breast milk of pregnant women and the oral cavity of 
their infants. Furthermore, the associations between human papillomavirus (HPV) 
infection and the bacterial microbiota were investigated. Similarities between the 
neonatal mouth microbiota directly after birth and the microbiota in the maternal 
mouth, cervix and placenta were assessed. In addition, the invasion of HPV positive 
cervical carcinoma cells to benign leiomyoma derived matrices and the impact of 
HPV viral load and ionizing radiation were evaluated in vitro. 
This study was based on 39 mother-infant pairs. The maternal mouth, cervix, placenta 
and breast milk, as well as the infant mouth were discovered to harbour a distinct bacterial 
microbiota, which varied between the anatomical regions. The bacterial microbiota of 
HPV-positive samples was significantly different from that of HPV-negative samples in 
both the mother’s and child’s mouth as well as in the cervix and placenta. It is of note that 
HPV-positive samples were found to exhibit more potentially pathogenic bacteria as 
compared to HPV-negative samples. The bacterial microbial community in the neonatal 
mouth immediately after birth shared features with that detected in the placenta. Similarity 
to the maternal birth canal or oral microbiota was less pronounced. In the experimental 
model, HPV-positive cervical carcinoma cells were able to invade myoma-based tissue 
models. The carcinoma cell line containing less HPV was slightly more invasive than the 
cell line containing more HPV, but there was no difference in the area of invasion. 
Exposure to ionizing radiation reduced carcinoma cell invasion.   
To conclude, there is a relationship between the bacterial microbiota composition 
and HPV infection in the maternal and infant mouth, uterine cervix and placenta. 
Infant oral colonization may begin before birth.  In the experimental myoma tissue-
model, the HPV viral load in carcinoma cell lines had only minor effect on cell 
invasion. In contrast, exposure to ionizing radiation reduced the depth and area of 
invasion of cervical carcinoma cells. 
KEYWORDS: human papillomavirus, HPV, bacterium, bacteria, microbiota, 
microbiome, woman, infant, neonate, oral, mouth, cervix, placenta, breast milk   
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TIIVISTELMÄ 
Ihmiskehon eri osien mikrobistolla voi olla suotuisia tai haitallisia vaikutuksia 
terveyteen. Bakteerit voivat suojata kehoa virusinfektioilta tai edesauttaa niiden 
tarttumista. Lisäksi virukset ja bakteerit voivat altistaa syövän kehittymiselle joko 
yksinään tai yhteisvaikutuksellisesti. Bakteerien ja virusten vuorovaikutukset ovat 
huonosti tunnettuja. 
Väitöskirjatutkimus keskittyi selvittämään raskaana olevien naisten ja heidän 
vastasyntyneiden lastensa suun limakalvojen, kohdunkaulan, istukan sekä 
äidinmaidon bakteerimikrobiston koostumusta ja sen yhteyttä ihmisen papillooma-
virusinfektioon (HPV). Tutkittiin myös sitä, vallitseeko äidin suun, kohdunkaulan ja 
istukan bakteerimikrobiston ja lapsen suussa heti syntymän jälkeen todetun 
mikrobiston välillä yhteys. Lisäksi arvioitiin HPV positiivisten kohdunkaulasolu-
linjojen invaasiokykyä hyvänlaatuisista myoomakasvaimista kehitettyihin matrikseihin 
sekä HPV virusmäärän ja ionisoivan säteilyn vaikutusta tähän invaasioon. 
Tutkimus perustui 39 äiti-lapsiparin näytteisiin. Äidin suussa, kohdunkaulassa, 
istukassa ja äidin maidossa sekä lapsen suussa todettiin niille ominainen 
bakteerimikrobisto, joka vaihteli anatomisten alueiden välillä. HPV-positiivisten 
näytteiden bakteerimikrobisto oli erilainen kuin HPV-negatiivisten näytteiden sekä 
äidin että lapsen suussa, kohdunkaulassa ja istukassa. Merkille pantavaa on, että 
HPV-positiivisissa näytteissä todettiin enemmän tautiprosesseihin liitettyjä 
bakteereita. Lapsen suun bakteerimikrobisto heti syntymän jälkeen muistutti eniten 
istukassa todettua mikrobistoa. Samankaltaisuus äidin synnytyskanavan tai suun 
bakteeriston kanssa oli vähäisempi. Kokeellisissa tutkimuksissa HPV-positiiviset 
kohdunkaulan syöpäsolut kykenivät invasoimaan myoomapohjaisiin kudosmal-
leihin. Vähemmän HPV:tä sisältävä solulinja invasoi hieman voimakkaammin kuin 
suuremman virusmäärän sisältävä solulinja, mutta invaasion pinta-alalla ei ollut 
eroa. Altistus ionisoivalle säteilylle vähensi syöpäsolujen invaasiota.  
Yhteenvetona voidaan todeta, että tutkittujen anatomisten alueiden bakteeri-
mikrobiston koostumuksen ja HPV-infektion välillä on yhteys. Vastasyntyneen 
lapsen suun mikrobisto voi alkaa muodostua kohdussa jo ennen syntymää. 
Kokeellisessa mallissa HPV:n virusmäärällä syöpäsolussa oli vain vähäinen vaikutus 
solujen invaasioon. Sen sijaan altistus ionisoivalle säteilylle merkittävästi vähensi 
syöpäsolujen invaasion syvyyttä ja pinta-alaa. 
AVAINSANAT: ihmisen papilloomavirus, HPV, bakteeri, bakteeristo, mikrobisto, 
nainen, lapsi, vastasyntynyt, suu, kohdunkaula, istukka, äidinmaito  
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1 Introduction 
The microbiome is defined as the microbiota and its environment, namely the human 
host. Microbiota is composed of bacteria, archaea, viruses and fungi. Host 
interactions shape the size, species composition and biogeography of microbial 
communities and the microbiota influences human health. Viruses are obligate 
intracellular pathogens. They require the host cell protein synthesis machinery to 
replicate. The interaction between the commensal microbiota and viruses is not clear. 
The microbiota may protect against or help to acquire viral infection, or it may 
promote viral evasion by direct or indirect mechanisms. The host’s microbiota may 
in addition increase or diminish cancer susceptibility. The causal relationship 
between viral-bacterial interactions is complex and its role in specific (pathological) 
events is difficult to demonstrate.  
Human papillomavirus (HPV) is relatively common human virus and around 
80% of the population will get the infection at some point of their life (Braaten and 
Laufer 2008; Chesson et al. 2014). Infection is usually acquired via horizontal 
transmission during sexual intercourse or in another close skin and/or mucosal 
contact. HPV can also be transmitted via vertical transmission and this has been 
observed mainly in the mother-infant context. A mother with present HPV infection 
can, for example, infect her infant during pregnancy or after delivery while taking 
care of the infant. Other possible infectious routes include haematogenous spread via 
circulating blood and ascending infection straight from vagina. (Syrjänen and 
Puranen 2000; Deng et al. 2005; Syrjänen 2010; Koskimaa et al. 2012; Park et al. 
2012; Freitas et al. 2013; Hahn et al. 2013; Liu, Rashid and Nyitray 2015; Trottier 
et al. 2016). 
HPV infects the epithelium and most of the infections remain asymptomatic. 
HPV can cause small epithelial lesions such as verruca, papilloma or condyloma. 
Within months, most of these infections are cleared by individuals own immune 
defence (Louvanto et al. 2010; Hibma 2012; Rautava et al. 2012a). The impacts of 
HPV infections in infants are currently not well known. It has been speculated that 
most of the infections in infants clear similarly to adults. HPV infection may also be 
latent, in which case HPV is preserved in the body, but it hides from immune defence 
system and it cannot be detected with traditional HPV detection methods (Gravitt 
Heidi Tuominen 
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and Winer 2017). Some HPV genotypes, called high-risk HPVs, may remain and 
cause a persistent infection. These persistent infections can, in the duration of years 
and decades, develop into squamous cell carcinoma (SCC) (Schlecht et al. 2001; 
Louvanto et al. 2010, 2011a). HPV causes nearly 100% of uterine cervix SCCs 
(Durst et al. 1983; Boshart et al. 1984; zur Hausen 2002, 2009). During the past 20 
years, it has been discovered that the HPV causes a major part of oropharyngeal 
SCCs (OPSCC) as well (Kreimer et al. 2005; Arbyn et al. 2012; Mehanna et al. 
2013). The natural history of oral HPV infection remains unclear.  
The impact of bacteria to human health and disease is well known. Commensal 
bacteria are present on body surfaces covered by epithelial cells and exceed the 
number of cells forming human body. Commensal bacteria co-evolve and protect 
their host. Under specific conditions they may overcome protective human responses 
and exert pathologic effects. Bacterial dysbiosis depicts a situation where the 
bacterial microbiota becomes instable and pathogenic conditions may occur. This 
dysbiosis alone may have an effect to e.g. inflammatory bowel disease, periodontitis 
and even to cancer or Alzheimer’s disease (Turnbaugh et al. 2009; Bäckhed et al. 
2012; Hsiao et al. 2013; Huttenhower, Kostic and Xavier 2014; Petersen and Round 
2014; Trompette et al. 2014; Garrett 2015; Wang et al. 2017; Karpiński 2019; 
Kowalski and Mulak 2019). 
The indigenous bacterial microbiota is established during early life. The mother 
is the most important source of colonizing bacteria (Yassour et al. 2018). For decades 
it has been believed that foetus develops in a sterile environment and encounters 
bacteria and viruses only after the delivery. In recent years, it has been suggested 
that placenta may harbour specific bacterial microbiota that could possibly have an 
effect on the developing foetus (Satokari et al. 2009; Rautava et al. 2012b; Stout et 
al. 2013; Aagaard et al. 2014; Collado et al. 2016; Gomez-Arango et al. 2017a; 
Parnell et al. 2017; Benny et al. 2019). 
This thesis focuses on the interaction between HPV and bacteria in the oral cavity 
of mothers and infants as well as uterine cervix, placenta and mother’s breast milk. 
The presence of HPV infection and the composition of bacterial microbiota were 
investigated from samples obtained from healthy Finnish pregnant women and their 
newborns before, during and after delivery. In addition, this work aimed to reveal 
the impact of mothers’ microbiota to the development of neonate’s oral microbiota 
during and directly after delivery. Further on the effect of different delivery modes 
to neonatal oral microbiota composition was also investigated. Another aspect of this 
study was to evaluate in vitro, how HPV positive cervical SCC cells can be cultivated 
in novel human extracellular matrices and additionally, to investigate the impact of 
different HPV copy numbers and irradiation to cell invasion.  
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2 Review of the Literature 
2.1 Human papillomavirus 
2.1.1 The virus structure 
Human papillomavirus (HPV) is a non-enveloped double-stranded circular DNA 
virus that has the potential to infect human epithelial cells. Over 200 HPV types 
have been identified today, and the different genera are divided to Alpha-, Beta-, 
Gamma-, Mu- and Nu -groups according to the nucleotide sequence of the L1 
protein (de Villiers 2013; Bzhalava, Eklund and Dillner 2015). Furthermore, alpha 
HPVs are further divided into groups according to predilection to mucosa or skin 
surface and to high-risk (HR) or low-risk (LR) types according to their oncogenic 
potential (de Villiers et al. 2004; de Villiers 2013; Bzhalava, Eklund and Dillner 
2015) 
The virus itself is composed of a double-stranded DNA structure and is about 
8.000 base pairs in length. The DNA genome can be divided into three functional 
domains; the long control region (LCR) and to early (E1-E7) and late (L1-L2) open 
reading frames (ORF’s) which have different functions to cell survival and viral 
production (Harden and Munger 2017) (Figure 1).  
Heidi Tuominen 
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Figure 1. HPV16 genome. (Kajitani et al. 2012). 
The E1, E2, E4, L1 and L2 are so called core genes which all have an essential 
function in cell viral genome replication and genome packaging and these proteins 
are somewhat conserved between different HPV types. The classification of HPVs 
is based on L1 nucleotide sequence. On the other hand, there are the accessory genes 
E5, E6 and E7. They modify the cellular environment to support and tolerate viral 
genome replication and to help the cell to survive in order to complete the viral life 
cycle in the site of infection. (Egawa and Doorbar 2017). The LCR controls the 
function of oncoprotein E6 and E7 and includes the transcriptional regulatory 
elements (Table 1). 
Classification of HPV according to biological behaviour 
The division to HR- and LR-HPVs present clinically significant differences. At first, 
the division was made after detecting certain genotypes more frequently in 
carcinoma specimens (Durst et al. 1983; Boshart et al. 1984; Schiffman et al. 1993). 
It was later noticed that LR-HPV types does not usually use their E6/E7 oncogenes 
as what HR-HPVs do in order to reach  excessive cell proliferation (Schwarz et al. 
1985; Yee et al. 1985). HR-HPV oncogenes E6 and E7 have a direct effect to cell 
differentiation process and have the ability to immortalize epithelial cells (Moody 
and Laimins 2010). The two groups (HR and LR) have different cell transcriptional 
Review of the Literature 
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regulation of these and other specific genes which make the LR-HPV less malignant 
(Egawa and Doorbar 2017). Consequently, HR-HPVs are more pathogenic and have 
the ability to develop precancerous lesions and even carcinoma after long 
persistence. The most often encountered HR-HPVs are 16 and 18, whereas 6 and 11 
in LR-HPVs. (de Villiers et al. 2004; de Villiers 2013; Egawa and Doorbar 2017). 
(Table 2) 
Table 1. HPV DNA protein functions. Modified from Egawa & Doorbar, 2017b. 
HPV protein Function 
E1 - required for origin of replication of viral DNA 
- maintains viral DNA as episomal 
- mediates the cell growth arrest 
E2 - initiates viral DNA replication; directs the E1 to the viral replication origin 
- regulates viral and cellular gene expression 
- induces cell growth arrest 
- serves as negative regulator of expression of E6/E7 oncogenes 
- maintains of viral DNA as episomal 
- encapsidates virion  
E4 - replicates viral DNA 
- arrests cell cycle 
- encapsidates viral genome 
- releases virion 
E5 - enhances the cell transforming activity of E6 and E7 
- controls cell growth and differentiation 
- prevents immune response against infected cell 
E6 - inhibits cell growth arrest, differentiation and apoptosis by degradation of 
p53 (major tumour suppressor protein) reducing the cell’s ability to respond 
to DNA damage 
- prevents telomere shortening during cell proliferation 
- induces loss of cell polarity 
E7 - induces cell hyperproliferation and productive viral life cycle by inhibition of 
retinoblastoma proteins (pRb, another tumour suppressor protein) 
- alters cell cycle control and gene expression 
- prevent apoptosis together with E6 and activates cellular telomerase 
L1 Major capsid protein 
- encapsidates the viral genome 
- is responsible of cell attachment during infectious entry 
L2 Minor capsid protein 
- encapsidates the viral genome 
- is responsible of viral cell entry into the host cell and viral genome transfer 
into the cell nucleus 
Heidi Tuominen 
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Table 2.  Differences of LR- and HR-HPV. Some of the HPVs are listed with clinical significance. 
Furthermore, main protein function differences are described. Modified from IARC 2012; 
Egawa and Doorbar 2017. 
 e.g. of 
HPV 
types 
The main differences in 
protein function  
The main 
differences in 
infection 
Clinical 
significance 
LR
-H
PV
 
 
HPV 6 
HPV 11 
HPV 83 
HPV 70 
 
E6: no degradation of 
p53 protein + no 
activation of telomerase 
E7: no destabilizing of 
pRb 
  
 
Little or no 
expression of E6/E7 
 
Benign lesions: 
(genital) warts 
condyloma 
papilloma 
H
R
-H
PV
 
 
HPV 16 
HPV 18 
HPV 58 
HPV 66 
 
 
E6: degradation of p53 
and inhibition of p53 
transactivation + 
activation of telomerase 
E7: destabilizing pRb 
 
 
E6/E7 inhibit 
immune response to 
tolerate viral gene 
expression 
 
Carcinogenic 
potential 
2.1.2 HPV transmission and infection 
HPV transmission 
Horizontal transmission (e.g. sexual interaction or other close skin and/or mucosa 
contact between individuals) or vertical transmission (e.g. from mother to infant) are 
thought to be the main HPV transmission methods (Oriel 1971; Schneider and 
Koutsky 1992; Burchell et al. 2006; Syrjänen 2010; Freitas et al. 2013). Today, HPV 
infection is mainly considered to be a sexually transmitted infection, and the main 
way of transmitting the virus (Oriel 1971; Burchell et al. 2006; Rautava and Syrjänen 
2011). Nevertheless, in addition vertical transmission has been observed. This has 
been reported to occur mainly between mother and her infant, either by prenatal 
transmission (via circulating peripheral blood, or as an ascending infection from 
cervix/vagina or as an infection via placenta/amniotic fluid), during delivery from 
cervix/vagina or during care-taking after the delivery (Syrjänen and Puranen 2000; 
Bodaghi et al. 2005; Deng et al. 2005; Rombaldi et al. 2008; Sarkola et al. 2008a; 
Chen et al. 2009; Syrjänen 2010; Park et al. 2012; Koskimaa et al. 2012, 2014; 
Freitas et al. 2013; Hahn et al. 2013; Hong et al. 2013; Merckx et al. 2013; Liu, 
Rashid and Nyitray 2015). HPV positive breast milk is not thought to be a risk factor 
for infant to acquire oral HPV infection (Sarkola et al. 2008b; Yoshida et al. 2011; 
Louvanto et al. 2017).  
Review of the Literature 
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Vaginal delivery has been detected to slightly increase the risk of HPV vertical 
transmission, but HPV have been observed to transmit even with caesarean section, 
supporting the concept of prenatal transmission (Wang, Zhu and Rao 1998; Xu et al. 
1998; Medeiros et al. 2005; Mammas et al. 2012; Chatzistamatiou, Sotiriadis and 
Agorastos 2016). HPV has been detected in epithelial cells of the placenta with In 
situ hybridisation (Sarkola et al. 2008a). A recent systematic review did not detect 
difference in HPV transmission between vaginally or caesarean section delivered 
infants (Zouridis et al. 2018) The risk of perinatal transmission of HPV infection has 
been estimated to be around 4%-24.5% (Medeiros et al. 2005; Castellsagué et al. 
2009; Rombaldi et al. 2009; Park et al. 2012; Hahn et al. 2013). HPV has been 
considered to be a threat to the pregnancy but there are several studies showing 
infection with normal, healthy births as well (Sarkola et al. 2008a; Koskimaa et al. 
2012; Trottier et al. 2016). 
One possible way of acquiring HPV infection is autoinoculation. In this case, 
individual infects itself again to another body site with already existing HPV 
infection (Brouwer, Meza and Eisenberg 2015). Furthermore, haematogenous spread 
of HPV may occur, since HPV has also been detected from amniotic fluid and cord 
blood samples (Armbruster-Moraes et al. 1994; Wang, Zhu and Rao 1998; Xu et al. 
1998; Sarkola et al. 2008a; Syrjänen 2010). The exact mechanism behind the 
possible HPV transmission via blood is so far unclear.  
HPV infection 
In order to infect a host, HPV requires some kind of wound, microtrauma or abrasion 
on the mucosa or skin surface in order to reach to the basal cells. The basal cells are 
the dividing epithelial cells, and thus essential for the virus to produce new viral 
copies. Furthermore, HPV can only infect and replicate in fully differentiated 
squamous epithelial cells. (Reinson et al. 2015). 
After reaching the target (basal) cell, the virus attaches to heparan sulphate 
proteoglycans (HSPG) with the L1 viral protein. After complex mechanisms, which 
are not yet fully understood, the virus enters the cell nucleus (Aksoy, Gottschalk and 
Meneses 2017). Thereafter, the viral early transcription starts by the activation of E1 
and E2 (Sanders and Stenlund 2000). The first round of replication results in total of 
50-100 episomal copies of HPV per nucleus (Maglennon, McIntosh and Doorbar 
2011). It has been observed, that in most of the HPV related carcinoma or its 
precursors, the HPV genome can be found integrated in the host cell genome (zur 
Hausen 2002). This allows greater expression of oncogenes E6 and E7 (Taberna et 
al. 2017). 
After the first round of viral DNA replication, the copy numbers are kept low 
and the function of the gene minimal in the dividing epithelial cells. There is a tight 
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control of viral proteins at this stage. The virus activates all its genes in a massive 
upregulation only after the cell stops dividing and starts to proliferate. At this stage, 
the number of HPV DNA copies can go up to thousands per cell. In the most 
superficial layer of the skin, the late proteins L1 and L2 are activated to encapsidate 
the viral genomes and the virions are released along with the shedding of the cells to 
infect a new host. (Stanley 2010). Schematic figure of viral life is presented in Figure 
2. 
 
Figure 2. HR-HPV viral life cycle in epithelial cells. The average time from infection to 
desquamation is around six weeks.   
2.1.3 Natural history, prevalence and clinical significance 
Around 80% of adult population have an HPV infection some time over the course 
of their life (Chesson et al. 2014). Around 11%-21% of small infants (0-3 months 
old), have been detected to be positive for HPV (Rintala et al. 2005a; Trottier et al. 
2016).  Of HPV infected, only a few percent will ever develop visually present 
symptoms of a disease such as verruca, papilloma or condyloma (Syrjänen et al. 
1990). These benign lesions are mainly caused by low risk (LR) HPVs (mainly 
genotypes 6 or 11). Even benign lesions can sometimes cause serious problems if 
they are located for example in the respiratory tract (known as infants recurrent 
respiratory papillomatosis, RRP) (Bauman and Smith 1996; Blackledge and Anand 
2000; Silverberg et al. 2003; Egawa and Doorbar 2017). 
Most of the HPV infections are cleared within few months after infection, but in 
some cases, HPV can persist (Louvanto et al. 2010; Hibma 2012; Rautava et al. 
2012a). Only a fraction of HPV infected individuals develop a persistent infection, 
which has the potential to proceed to malignancy. Especially, high-risk (HR) HPVs, 
such as HPV16 or HPV18, have a potential to cause persistent infections (Schlecht 
et al. 2001; Louvanto et al. 2010, 2011a; Rautava et al. 2012a) and HR-HPVs can 
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predispose to the development of squamous cell carcinoma (SCC). Still, HPV 
infection progression to carcinoma is relatively rare event taking into account the 
number of HPV infected individuals (Stanley 2010). 
2.1.4 HPV induced squamous cell carcinoma in cervix and 
in head-and-neck region (HNSCC) 
The hypothesis of the cervical carcinoma association to HPV was first introduced  in 
the 1970s (Hausen et al. 1974) and first HPVs were isolated in cervical carcinoma 
biopsies in the 1980s (Durst et al. 1983). The role of HPV in cervical carcinoma has 
since been extensively studied, and HPV can be found in nearly all of the cervical 
SCC specimens (IARC 2004). Cervical carcinoma screening has been introduced 
already decades ago to detect HPV induced premalignant changes in the female 
cervical region to help prevent carcinoma development (Franceschi et al. 2011; 
Arbyn et al. 2012). In addition to cervical SCC, HPV has the potential to cause 
disease in the anogenital region (zur Hausen 2009; Stanley 2010). 
A growing body of evidence shows that HPV infection is partially responsible 
for the rapidly growing numbers of the head-and-neck squamous cell carcinomas 
(HNSCC) and especially SCCs in the oropharyngeal region (OPSCC) (Kreimer et 
al. 2005; Arbyn et al. 2012; Mehanna et al. 2013). Around 35% - 87 % OPSCC have 
been detected to be HPV positive (Hansson et al. 2005; Gillison et al. 2015; 
Ducatman 2018). The most often detected genotype is HPV16 (Herrero et al. 2003; 
Hansson et al. 2005; Kreimer et al. 2005; Rautava et al. 2012a).  
HPV DNA detection in carcinoma does not prove a causal relationship; HPV 
may be a bystander, not causing the disease. To detect active HPV infection, the 
most often used biomarker is p16 immunochemistry (IHC) by the E7 oncoprotein. 
(Ducatman 2018; Ruuskanen et al. 2018). The p16 is a common tumour suppressor 
gene found in almost all cancers. It’s main function is to inhibit cell growth and p16 
is often overexpressed in HPV associated carcinomas. (Serra and Chetty 2018). 
However, p16 method is indirect and not specific to only HPV infection and there is 
a risk of misclassification (Rayess, Wang and Srivatsan 2012; Salles et al. 2014; 
Jouhi et al. 2017; Belobrov et al. 2018). The disease burden of HPV induced 
oropharyngeal carcinoma has been increasing in recent years especially to otherwise 
healthy, young patients who generally do not smoke or consume large amounts of 
alcohol (IARC 1985; Chaturvedi et al. 2011; Gillison et al. 2012, 2014; Young et al. 
2015; Taberna et al. 2017). 
The cervix and oropharyngeal sites have been speculated to be the predominant 
target of HPV infection because of the so-called transformation zone (Gillison et al. 
2014; Chen and Zhou 2015; Mallen-St Clair et al. 2016). This area in the cervix and 
in the oropharyngeal region consists of the interface between the squamous and 
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columnar epithelial cells. The basal cells are more exposed at this site where there is 
constant changing of cell morphology. Figures 3 and 4 present the gross anatomy 
of the oral cavity and oropharynx, respectively. 
 
Figure 3.  The oral cavity. Figure modified from MIS 65-5390-1, National Museum of Health and 
Medicine, Otis Histological Archives. 
Epiglottis 
Larynx 
Pharynx 
Nasopharynx  
Oropharynx  
Nasal cavity 
Oral cavity  
 
Esophagus 
Review of the Literature 
 21 
 
Figure 4.  Cross-section of oral, nasal and pharyngeal regions. Soft palate and base of tongue 
are part of oropharynx. Figure modified from Wikimedia Commons by Pearson Scott 
Foresman. 
HPV positive OPSCC exhibits a more favourable response to treatment and 
especially radiation treatment than HPV negative OPSCCs which are mainly caused 
by tobacco and alcohol use (IARC 1985; Ang et al. 2010; Chaturvedi et al. 2011). 
The latest WHOs classification even separates HPV positive and HPV negative 
OPSCC into different diseases since the behaviour of the tumour is significantly 
different (El-Naggar et al. 2017). This difference according to HPV status has not 
been detected in all studies (Nagel et al. 2013; Schneider, Bol and Grégoire 2017; 
Taberna et al. 2017). Furthermore, the new TNM staging system classification takes 
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into account the HPV status of the OPSCC (Brierley, Gospodarowicz and Wittekind 
2010). 
2.1.5 HPV detection methods 
There is no golden standard method to detect HPV infection (Abreu et al. 2012). For 
research purposes, HPV DNA detection is the main laboratory analysis method to 
detect HPV in a sample. 
One of the most common HPV detection methods in research today is based on 
HPV viral DNA nucleic acids detection and amplification by polymerase chain 
reaction (PCR). It can be used in both swab samples and with tissue biopsies. PCR 
is based on primers that target specific conserved regions in the HPV genome, often 
in either L1 or E1, which enables detection of multiple different HPV genotypes in 
one assay run. The end-results are visualized with a scanner after washing steps. This 
technique is flexible, specific and very sensitive but possible contamination by 
previous material may result in false positive samples. Additionally, PCR is not ideal 
for detecting multiple simultaneous HPV infections with low copy numbers. Another 
issue regarding PCR HPV detection is that the method only reveals if HPV is present 
in a sample, but no conclusions can be drawn regarding whether the infection is 
active or if the HPV has induced carcinoma. Therefore, more precise detection 
methods of HPVs clinical relevance are used such as HR-HPV E6/E7 mRNA 
detection, ISH and IHC to detect the expression of the p16 protein. However, p16 is 
not specific to only HPV and there is a genuine risk for misclassification. (Brink, 
Snijders and Meijer 2007; Snijders, Heideman and Meijer 2010; Abreu et al. 2012; 
Rayess, Wang and Srivatsan 2012; Ndiaye et al. 2014; Salles et al. 2014; Jouhi et al. 
2017; Belobrov et al. 2018; de Souza et al. 2018; Ducatman 2018; Serra and Chetty 
2018). A recent review concluded HPV p16 sensitivity to be 90.5 % and specificity 
83.3 % (Jouhi et al. 2017). 
2.2 The human microbiota 
A vast number of microbes including bacteria, viruses, fungi and archaea colonize 
and inhabit the skin and mucosal surfaces of the human body. Germ free mice have 
been widely used in research in decades and it has been proven that without 
microbiota the mice will not behave or develop normally (Round and Mazmanian 
2009; Heijtz et al. 2011). Healthy interaction and homeostasis between the host and 
the microbiome is essential for the function of the human body and, consequently, 
life without microbiota is not possible (Gilbert and Neufeld 2014).  In this thesis, the 
word microbiota is used to describe mainly the bacterial microbiota. 
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The microbiota starts to develop gradually before and after the delivery (Jiménez 
et al. 2008; Collado et al. 2016). Full term or preterm pregnancy and the delivery 
mode (vaginal or caesarean section) have been shown to shape the structure of the 
early microbiota composition in newborns, as well as possible perinatal antibiotic 
treatments and neonates feeding methods (breast milk of formula) (Dominguez-
Bello et al. 2010, 2016; Lif Holgerson et al. 2011; Aujoulat et al. 2014; Jakobsson 
et al. 2014; Mueller et al. 2015; Blaser and Dominguez-Bello 2016; Nuriel-Ohayon, 
Neuman and Koren 2016; Chong, Bloomfield and O’Sullivan 2018). Most of these 
initial changes in the bacterial microbiota composition starts to settle after some 
months of life. However, absence or short duration of breast feeding or infant 
antibiotic treatment leave a trace in the bacterial microbiota composition even to later 
in life. (Dzidic et al. 2018b). Six to 12 months of age, after the end of breast feeding, 
the infant gut microbiota starts to resemble more adult gut microbiota (Bäckhed et 
al. 2015). Similarly, in the oral cavity, the microbiota matures during the first years 
of life (Lif Holgerson et al. 2015; Nuriel-Ohayon, Neuman and Koren 2016; Dzidic 
et al. 2018b).  
The adult gut microbiota is one of the most studied microbiota niches in human 
body. Generally, it is regarded that more diverse microbiota with a large number of 
beneficial species is better for health (Turnbaugh et al. 2007). The amount of the 
overall bacterial volume differs dramatically between regions. Estimated amounts of 
different taxa and volume of bacteria in selected body sites are presented at Figure 
5. 
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Figure 5.  The number of different bacterial species and an average number of bacteria in 
different body sites. Human figure from ClipArtMag.com 
2.2.1 Microbiota in health and disease 
The microbiota interacts with multiple human body functions. It can e.g. modulate 
innate and adaptive immune physiology, modify the food intake, affect appetite 
signalling pathways, take part in multiple vitamin biosynthesis, protect from 
exogenous pathogens and produce antimicrobial substances (Wang et al. 2017). These 
effects are considered to be beneficial in everyday life. However, if something distorts 
microbiota homeostasis and/or some pathogenic bacteria become more abundant, 
disease can also occur as a result of the changed bacterial microbiota composition. 
Dysbiosis is used to describe a condition where abnormalities occur in otherwise 
balanced system (Petersen and Round 2014). Increasing evidence has emerged 
suggesting that early bacterial colonization may have a significant impact to health 
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later in life. Several diseases have been connected to alterations in microbiota 
composition. Inflammatory bowel disease, type I and II diabetes, obesity, allergies, 
asthma, autism, Alzheimer’s disease and cancer are some of the most thoroughly 
studied diseases where a certain bacterial microbiota composition has been 
suggested to predispose the individual to disease development (Turnbaugh et al. 
2009; Bäckhed et al. 2012; Hsiao et al. 2013; Huttenhower, Kostic and Xavier 2014; 
Petersen and Round 2014; Trompette et al. 2014; Garrett 2015; Wang et al. 2017; 
Karpiński 2019; Kowalski and Mulak 2019).  
The dilemma lies in the extremely complex nature of these disease and therefore, it 
is difficult to isolate only one cause to a disease, especially in humans where there are 
numerous everchanging variables which may affect simultaneously. Especially 
abnormal microbiota composition in the gut in infancy has been shown to have an impact 
to individuals’ health in the following years to come, as it may precede e.g. allergies and 
asthma (Kalliomäki et al. 2008; Vael and Desager 2009; Abrahamsson et al. 2014; 
Nylund et al. 2014; Pärtty et al. 2015; Rodríguez et al. 2015; Saari et al. 2015; Isolauri, 
Salminen and Rautava 2016; Tanaka and Nakayama 2017; Zhuang et al. 2019).  
Interaction between an individuals’ microbiota and the environment is dynamic. 
However, individually there are usually no major fluctuations of the microbiota 
composition over time (Ursell et al. 2012). On the other hand, between individuals, 
however, the microbiota composition may vary widely according to age, sex, race 
and diets within health and disease (Huttenhower et al. 2012). Furthermore, vast 
geographical variation of the microbiota composition has been observed (Lloyd-
Price, Abu-Ali and Huttenhower 2016). Generally, a diverse microbiota is 
considered beneficial for human health, but not all body regions benefit from diverse 
microbiota composition. For example, the vaginal microbiota in a healthy situation 
is predominantly dominated by different Lactobacillus species, which are thought to 
be necessary for maintaining the overall health (Gupta, Kakkar and Bhushan 2019; 
Rinninella et al. 2019). In the vagina, shifts in the balance to more diverse microbiota 
can trigger the onset of bacterial vaginosis or even preterm birth in pregnant women 
(Fredricks, Fiedler and Marrazzo 2005; DiGiulio et al. 2015; Wang et al. 2017). 
The bacterial microbiota may be modulated intentionally with prebiotics or 
probiotics or the modulation can be unintentional (Rautava et al. 2012b; Sánchez et 
al. 2017). The International Scientific Association for Probiotics and Prebiotics 
(ISAPP) defines probiotics as “live micro-organisms which when administered in 
adequate amounts confer a health benefit on the host” (Hill et al. 2014). Probiotics 
are living non-pathogenic bacteria which often have a positive effect on human 
microbiota, e.g. lactic acid bacteria, such as Lactobacillus and Bifidobacterium, and 
these have been encouraged to use alongside antibiotics treatment to hep to restore 
bacterial microbiota in the gut and to avoid adverse side-effects of antibiotic 
treatment (Williams 2010). Prebiotics, on the other hand, defined by ISAPP as “a 
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substrate that is selectively utilized by host micro-organisms conferring a health 
benefit” (Gibson et al. 2017). Generally, these are considered as non-digestible food 
ingredients which beneficial gut bacteria (especially Lactobacillus and 
Bifidobacterium) can utilize as food and therefore succeed (Nicolucci et al. 2017). 
In recent years, the effect of vaccination, and the immune responses it generates, 
has been connected to an individuals’ bacterial microbiota composition. Antibiotic 
exposure may induce drastic changes in the composition of gut microbiota for up to 
six months in otherwise healthy adults (Palleja et al. 2018). The gut microbiota is 
known to play a key role in human immune system development and maturation 
(Lazar et al. 2018). Recent studies suggest that different microbiota composition 
during vaccination, with or without antibiotics, soon after the course of antibiotics 
or during antibiotic treatment, could decrease the development of sufficient response 
to vaccination (Jamieson 2015; Zimmermann and Curtis 2018). 
2.2.2 Bacterial 16S rRNA 
The indigenous bacteria generally represent a wide variety of different species and 
their structure and other features have significant differences. In order to study 
bacteria and to categorize them, a highly conserved part of the ribosomal subunit, a 
16S rRNA gene, has been used (Clarridge 2004). 16S is a part of the small subunit 
of bacterial ribosome. The ribosome is responsible of protein synthesis via mRNA 
for cell function (Wilson and Cate 2012).  
There are different regions in the 16S rRNA and some of these regions are 
conserved while others more variable (Clarridge 2004; Chakravorty et al. 2007). The 
conserved regions of the 16S rRNA gene have been observed to be very similar 
between different taxa and basically no mutation has been occurred in its structure over 
the duration of millions of years of bacteria evolution (Woese 1987). This makes it 
possible to design universal primers to target 16S rRNA for vide variety of different 
bacteria (Woese et al. 1975). The general approach of 16S-based microbiota analysis 
is to use a primer that can target the conserved region and then amplify the variable 
region. Different bacterial taxa can then be distinguished from each other based on the 
variable regions. In total, there are nine conserved and another nine variable regions in 
one 16S rRNA gene (Figure 6). (Petrosino et al. 2009). 
 
Figure 6.  The highly conserved (C1-C9) and highly variable (V1-V9) regions of the 16S rRNA 
gene. 
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2.2.3 Bacterial taxonomy 
As with HPVs, bacteria have their own classification designed to help categorizing 
different species by their structure. At first, the classification was based on the 
appearance of bacteria under light microscopy (Palleroni 2010). Nowadays, more 
specific identification method is used based on the 16S rRNA gene sequences. The 
unknown 16S rRNA gene, which is being investigated,  is being amplified and 
compared to a database with the existing taxonomical hierarchy being known (Cole 
et al. 2009; Rajendhran and Gunasekaran 2011). In Figure 7 some oral bacteria are 
being categorized by their bacterial taxonomy.  
  
H
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Class Family Genus Species Order Phylum 
Figure 7. Examples of taxonomic microbiota composition in the oral cavity. 
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2.2.4 Microbiota analysing methods 
Previously, culturing was the only available method to analyse the bacteria by their 
shape and primitive function. Non-cultivation methods, such as Fluorescence In Situ 
Hybridization (FISH) emerged in the 90’s. Since the achievements of computational 
technology and molecular techniques, the possibilities of microbiota analysing have 
grown exponentially. 
The 454 sequencing method was used to detect bacterial DNA in the beginning 
of 21st century. The 454 was considered the first next-generation DNA sequencing 
method that became commercially successful. It utilized pyrosequencing and was 
considered as the cutting edge at that time due to its speed but it was somewhat prone 
to errors and has later subsided for faster and cheaper methods. (Liu et al., 2012; 
Mardis, 2008). 
Today, the microbiota is often analysed by next-generation sequencing (NGS) 
of the 16S rRNA gene. Each bacterium can have several 16S rRNA genes and by 
amplifying that gene by a specific target region, it is possible to detect present 
microbiota (Liu et al. 2012). The amplified sequences are grouped together to form 
operational taxonomic units (OTUs) and selected groups are then compared to 
already existing databases to generate microbiota data composition in a selected area. 
Strict quality control is necessary in order to clean the generated bacterial data from 
possible contaminants and, for example, to remove possible chimeras generated 
during amplification (Edgar et al. 2011; Ursell et al. 2012). 
A new emerging way of analysing microbiota is so called whole genome 
sequencing (WGS), in which the entire bacterial genome is sequenced at a single 
time. One of the main advantages is that it provides more accurate bacterial 
sequences and might reveal even totally new species. Furthermore, WGS provides 
information regarding microbiota functions beyond mere identification of taxa. On 
the downside, it is still somewhat too expensive for extensive analyses and takes a 
relatively long time to process. Nevertheless, efforts are being made to reduce the 
cost of whole genome sequencing dramatically in order to produce more accurate 
science and a drastic reduction in sequencing costs has already been experienced 
(Ursell et al. 2012).  
Third generation sequencing (TGS) is under development for the future. The 
main advantages include that it reads nucleotides at single molecular level and does 
not require DNA strand splicing, amplification and synthesis. Also, the speed of 
analysing and simple sample preparation offers promising prospects for future 
research. Still, the rate of errors is higher than with NGS preventing scientist for 
developing commercial derivates. (Bleidorn 2016). 
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2.3 HPV and bacterial interactions 
Bacteria and viruses constitute a complex that is continually changing in response to 
external and internal stimuli. Since bacteria and viruses interact with each other 
constantly and one could impact to other’s function, it is meaningful to study the 
interactions between these two. The objective of studying viral-bacterial interactions 
is to understand these sufficiently to recognise their impact on human health. 
Furthermore, we need to understand when dysbiosis occur and how to remedy it 
when necessary. The ultimate goal in the future is to discover new therapeutic targets 
for the treatment of disease. (Almand, Moore and Jaykus 2017).  
In lung diseases, simultaneous co-infections with a virus and bacterium can 
result in higher severity of illness (Deng 2013). In the respiratory tract, it is believed, 
that present viral infection predisposes the individual to bacterial infection as well as 
a result of alterations in epithelial and immune cells (Deng 2013; Bellinghausen et 
al. 2016). The opposite situation may occur as well, when bacteria infect the subject 
first and establish an environment prone to viral co-infections (Bellinghausen et al. 
2016; Almand, Moore and Jaykus 2017). Similar results have been shown in the gut 
as well (Monedero, Buesa and Rodríguez-Díaz 2018). On the other hand, there is 
evidence that the microbiota may improve the influence of immune defence against 
viral infection (Ichinohe et al. 2011). 
Below, the microbiota composition in specific body sites of women and infants 
are described in greater detail. Furthermore, the HPV prevalence is explained as it is 
currently known as well as interactions between HPV and bacterial microbiota.  
2.3.1 Women 
Oral cavity 
The oral cavity harbours around 600-700 different bacterial species and the total 
volume of bacteria is around 1011 bacteria/ml (Dewhirst et al. 2010; Kilian et al. 
2016; Sender, Fuchs and Milo 2016) (Figure 5). The oral cavity is the only area in 
the human body where hard tissue, teeth, reaches outside the soft tissue, the gingival 
mucosa. This offers different tissues and surfaces for bacteria colonization in the 
mouth; teeth, three different types of mucosa, the gingival sulcus and furthermore 
the tonsils in the oropharynx. They all present unique characteristics for bacterial 
biofilm formation (Figures 3 and 4). Most studies investigating the oral microbiota 
have obtained their samples with mucosal swabs or as saliva samples and it is 
therefore difficult to dissect which oral environment the samples represent.  
Almost all oral diseases are infections: caries, gingivitis and periodontitis as well 
as endodontic infections and alveolitis (Table 3). The oral microbiota has been 
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associated with cardiovascular diseases, preterm birth, pneumonia and various 
gastrointestinal cancer (Offenbacher et al. 1998; Joshipura et al. 2003; Beck and 
Offenbacher 2005; Seymour et al. 2007; Awano et al. 2008; Michaud and Izard 
2014; Karpiński 2019). 
Table 3. The main pathogenic bacteria in periodontal disease and in dental caries, 
respectively. Modified from Awadh Al-Shahrani 2019; Könönen, Gursoy and Gursoy 
2019. 
Periodontal disease Dental caries 
 
Aggregatibacter actinomycetemcomitans 
Porphyromonas gingvalis 
Tannerella forsythia 
Treponema denticola 
 
Prevotella intermedia 
Prevotella nigrescens 
Parvinomas micra 
Campylobacter rectus 
Fusobacteium nucleatum 
 
 
Streptococcus mutans 
 
Lactobacilli spp. 
Actinomyces spp. 
 
The Human Oral Microbiome Database (HOMD) lists the most prevalent phyla in 
adult human oral cavity to be composed by Firmicutes, Bacteroidetes, 
Proteobacteria, Actinobacteria and Fusobacteria (Dewhirst et al. 2010; Huse et al. 
2012; Wade 2013) (Figure 7). Since the oral cavity is under a constant exposure to 
exogenous micro-organisms while eating, drinking and breathing, it is not easy to 
determinate which specific species are indigenous and which are only transient 
(Dewhirst et al. 2010).  
The prevalence of adult oral HPV infection has been reported to range from 3.6% 
- 34%. HPV infection in the oral cavity has previously been connected with risky 
sexual behaviour (several partners, practice of oral sex), simultaneous infection by 
human immunodeficiency virus (HIV infection), the presence of genital warts, older 
age and smoking. (Rintala et al. 2005b; Kreimer et al. 2010; Gillison et al. 2012). 
Spousal persistent oral HPV infection is a risk-factor for persistent oral HPV 
infection in the another spouse (Rintala et al. 2006). We have previously shown, that 
oral HPV infection prevalence in the mother is lower before delivery (16%) than two 
years after (27%) (Rintala et al. 2005b). This might indicate that pregnancy may 
enhance immune defence and result in not acquiring HPV or clearing the present 
HPV infection.  Around 7% of mothers cleared the infection and another 7% 
persisted in the 24-month follow-up (Rintala et al. 2006).  
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Our current understanding of the interactions between HPV infection and the 
oral microbiota in adults is very limited. Guerrero-Preston an colleagues (Guerrero-
Preston et al. 2016, 2017) presented higher amount of Lactobacillus 
gasseri/johnsonii, Lactobacillus vaginalis and Gemellaceae genus in saliva samples 
from HPV positive HNSCC patients. These bacterial species have previously been 
connected to higher caries levels in another study (Caufield et al. 2015). 
Cervix 
The uterine cervix and vaginal microbiota are mainly dominated by Lactobacillus 
species, the main function of which is to regulate the acid pH by lactic acid production. 
The vaginal/cervical microbiota are often divided into specific groups according to 
which Lactobacillus species is the dominant one; L. crispatus, L. gasseri, L. iners or 
L. jensenii. (DiGiulio et al. 2015; Lloyd-Price, Abu-Ali and Huttenhower 2016; Di 
Paola et al. 2017). Hormonal changes during life (normal menstrual cycle, hormonal 
contraceptive use and pregnancy) all have effect to the vaginal microbiota composition 
in addition to geographical differences and race (Ravel et al. 2011; Gajer et al. 2012; 
Anahtar et al. 2015; Nuriel-Ohayon, Neuman and Koren 2016; Brooks et al. 2017). 
Shifts in this balance to more diverse microbiota and lower levels of Lactobacillus spp. 
have been linked to bacterial vaginosis, cervical intraepithelial neoplasia and its 
severity and even to pre-term birth in pregnant women (DiGiulio et al. 2015; Mitra et 
al. 2015a, 2015b, 2016). Bacterial vaginosis is characterized by lower levels of 
Lactobacillus spp. and higher levels of Preveotella species, Mycoplasma hominis and 
Atopobium vaginae (Gillet et al. 2011; Di Paola et al. 2017). 
Cervical HPV infection is observed in around 18.9% - 75% of adult women and 
is thus a fairly common finding (Eppel et al. 2000; Worda et al. 2005; Paaso et al. 
2011; Koskimaa et al. 2012; Park et al. 2012; Uribarren-Berrueta et al. 2012; 
Brotman et al. 2014; Steinau et al. 2014; Mitra et al. 2015b). HPV16 infection is the 
most prevalent HPV genotype in cervical region (Louvanto et al. 2011a; Zhao et al. 
2014; Santos Filho et al. 2016; Hooi et al. 2018; Ge et al. 2019). Risk-factors for 
cervical HPV infection include multiple life-time sexual partners, initiation of oral 
contraceptive use after 20 years of age and young (<13 years) age at initiation of 
smoking, multiple sexual partners and sexual activity (Louvanto et al. 2011a; Shi et 
al. 2017; Hooi et al. 2018).   
Decreased levels of Lactobacillus and increased diversity in cervical microbiota 
have been shown to have a positive correlation with present HPV infection and its 
persistence and severity of disease (Gillet et al. 2011; Gao et al. 2013; Mitra et al. 
2016; Di Paola et al. 2017; Kero et al. 2017; Mortaki et al. 2019). Levels of 
Gardnerella vaginalis and Atopobium vaginae have been reposted to be significantly 
higher in HPV positive cervical samples (Gao et al. 2013; Di Paola et al. 2017). It is 
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already relatively clear that the vaginal microbiota is associated with HPV infection 
but the direction of causality between the two remains unclear (Mortaki et al. 2019). 
Placenta 
The schematic illustration of the placenta structure is presented in Figure 8. The 
main function of the placenta is to provide nutrients and oxygen to the developing 
foetus while clearing waste products. In addition, the placenta secretes hormones 
which are necessary for the continuation of the pregnancy. (Gude et al. 2004). 
 
Figure 8.  The gross anatomy of the placenta. The embryo is about two months old. 
The presence of microbes in the placenta was suggested a few years ago. The placenta 
reportedly harbours mainly Proteobacteria, Prevotella, Streptococcus and Veillonella 
(Satokari et al. 2009; Rautava et al. 2012b; Stout et al. 2013; Aagaard et al. 2014; 
Collado et al. 2016; Gomez-Arango et al. 2017a; Parnell et al. 2017; Benny et al. 2019). 
The placenta microbiota has been suggested to resemble the adult oral microbiota 
(Aagaard et al. 2014). Though, not all studies have been able to corroborate these 
findings (Lauder et al. 2016; de Goffau et al. 2019; Theis et al. 2019). The problem 
with determination of placenta microbiota lies in the small number of detectable 
bacteria. This makes it difficult to distinguish true bacterial colonisation from 
contamination. Furthermore, researchers have not been able to consistently cultivate the 
bacteria detected in placenta to show their viability. (Perez-Muñoz et al. 2017).  
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Nevertheless, statistically significant differences in the placenta microbiota have 
been observed in term versus preterm deliveries, in mothers who gain excess weight 
during pregnancy, in mothers with gestational diabetes, in case of pre-eclampsia, 
chorioamnionitis and according to neonate’s birth weight, when compared placenta 
samples from a healthy pregnancy. Increasing evidence  suggests that some bacteria 
might be present in the healthy placenta. (Queiros da Mota et al. 2013; Amarasekara 
et al. 2015; Antony et al. 2015; Zheng et al. 2015, 2017a, 2017b; Lloyd-Price, Abu-
Ali and Huttenhower 2016; Doyle et al. 2017; Benny et al. 2019; Younge et al. 
2019). 
In the placenta, HPV is reportedly detected in 5.7% - 85% of the cases studied. 
HPV has been localized into the trophoblast (epithelial) cells. (Hermonat et al. 1998; 
Liu et al. 2001; Gomez et al. 2008; Rombaldi et al. 2008; Sarkola et al. 2008a; Weyn 
et al. 2011; Skoczyński, Goździcka-Józefiak and Kwaśniewska 2011; Uribarren-
Berrueta et al. 2012; Chisanga et al. 2015; Slatter et al. 2015; Ambühl et al. 2016; 
Trottier et al. 2016; Bober et al. 2019). The presence of HPV in the placenta has 
been observed to increase the risk of spontaneous abortion and chorioamnionitis (Liu 
et al. 2001; Gomez et al. 2008; Slatter et al. 2015; Ambühl et al. 2016; Bober et al. 
2019). However, HPV positivity in placenta has also been detected with healthy 
pregnancy and birth in several studies (Sarkola et al. 2008a; Koskimaa et al. 2012; 
Lee et al. 2013b; Trottier et al. 2016). 
Bacterial inflammation and infection of the placenta, even without the presence 
of HPV, is a known risk-factor for extremely preterm deliveries (Trivedi et al. 2012). 
Furthermore, specific bacterial such as Ureaplasma species, in the vagina, cervix 
and placenta, have been linked with chorioamnionitis and preterm deliveries (Kwak 
et al. 2014; Cox et al. 2016; Sweeney et al. 2016). There is no information about 
present HPV infection interactions to microbes in the placenta. 
Breast milk 
The microbiota of human breast milk is composed mainly of Streptococceae, 
Staphylococcaceae, Pseudomonadaceae and Bifidobacteriaceae. The milk microbiota 
composition has been observed to be unique to each mother showing also geographical 
differences (Hunt et al. 2011; Urbaniak et al. 2014; Boix-Amorós, Collado and Mira 
2016; Biagi et al. 2017; Li et al. 2017b). The delivery mode affects the bacterial 
composition of breast milk, as well as the mothers’ weight. Fluctuation in breast milk 
bacterial composition is observed over the course of lactation (Cabrera-Rubio et al. 
2012; Li et al. 2017b; Hermansson et al. 2019). Besides bacteria, breast milk contains 
oligosaccharides, proteins, immunoglobulins (such as IgA) and lipids and provides all 
the essential ingredients for infants’ nutrition (Nuriel-Ohayon, Neuman and Koren 
2016; Aakko et al. 2017; Mosca and Giannì 2017). 
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Around 2.5% - 21% of breast milk have been observed to harbour HPV, which 
is thought to shed from ductal epithelial cells (Sarkola et al. 2008b; Yoshida et al. 
2011; Glenn, Whitaker and Lawson 2012; Diaz et al. 2018). Not all studies have 
been able to detect any HR-HPVs in breast milk (Mammas et al. 2011). HPV in 
breast milk has been observed to be a risk-factor for the spouse to acquire oral HPV 
infection (Louvanto et al. 2017). There are currently no reports on interactions 
between HPV and bacterial composition in breast milk. 
2.3.2 Infant 
The development of the oral cavity microbiota 
Neonatal gut microbiota has been suggested to start developing already in utero. The 
same has not yet been observed in the oral cavity despite the close connection of the 
two via the gastrointestinal tract. (Collado et al. 2016). The neonatal oral cavity 
microbiota is known to be very delicate and easily affected by outer factors such as 
delivery mode, antibiotics given to mother during delivery and by the mode of 
feeding (Dominguez-Bello et al. 2010; Lif Holgerson et al. 2011; Al-Shehri et al. 
2015; Drell et al. 2017; Gomez-Arango et al. 2017b; Timby et al. 2017; Dzidic et 
al. 2018b; Li et al. 2018).  
Directly after delivery and during the first months of life, the main oral bacterial 
taxa consist mainly by Streptococcus and Staphylococcus. In the following months 
the Gemella, Actinomyces and Veillonella becomes more abundant. (Sampaio-Maia 
and Monteiro-Silva 2014; Biagi et al. 2017; Dzidic et al. 2018b). Changes detected 
in the oral microbiota during the first few weeks of life caused by differences in 
delivery mode are no longer detectable after six weeks of life (Chu et al. 2017). Some 
changes in the bacterial microbiota composition emerge again when deciduous teeth 
erupt (Cephas et al. 2011; Sampaio-Maia and Monteiro-Silva 2014). The oral 
microbiota maturation continues during the entire childhood (Crielaard et al. 2011; 
Dzidic et al. 2018b). It has recently been suggested that maternal microbiota might 
influence to the neonatal oral microbiota development, and that especially bacteria 
detected in the placenta might contribute significantly to neonatal oral microbiota 
development (Younge et al. 2019). 
HPV and microbiota in the infant oral cavity 
HPV infection in healthy newborns oral cavity has been observed to fluctuate 
between 0.9% - 14.3 % (Rintala et al. 2005b; Castellsagué et al. 2009; Rombaldi et 
al. 2009; Smith et al. 2010; Martinelli et al. 2012; Park et al. 2012; Hahn et al. 2013; 
Trottier et al. 2016). The main studies from the past ten years are listed in Table 4. 
Heidi Tuominen 
 36
Table 4. The prevalence of infant oral HPV infection. Study group, country, number of 
participants, sample, type, HPV detection method, the oral HPV presence and the most 
prevalent HPV genotypes are listed.   
Country 
study 
population 
Number 
of 
subjects Sample 
HPV 
detectlon 
method 
Oral HPV 
+ve% 
Basellne 
(at blrth) 
OralHPV 
+ve%  
1–2  
months 
OralHPV 
+ve%  
6  
months 
Most 
prevalent 
HPV 
genotypes 
Brazll 63 buccal 
swab 
multlplex 
PCR and 
nested 
multlplex 
PCR 
12.2% 10.2% 2% HPV 6 & 
11 
(53.3%) 
Spaln 117 oral swab PCR 6.0% 12.7% 9.1% HPV 16 
(30.8%) 
USA 333 oral swab PCR 0.9% 
(wlthln 24 
hours after 
dellvery) 
N.A. N.A. HPV 16 
(0.9%) 
ltaly 14 to 42 oral- 
pharyngeal 
swab 
nested 
PCR 
7.7% 9.4% 14.3% HPV 81 
(20%) 
South 
Korea 
291 oral 
mucosal 
scrape 
PCR 3.4% N.A. 0% HPV 16 
(20%) 
Republlc of 
Korea 
469 oral swab PCR 3.2% N.A. N.A. HPV 53 
(12.5%) 
Canada 67 buccal 
swab 
PCR 8.1% N.A. N.A. HPV 89 
(40%) 
 
The risk-factors in parent related transmission of HPV infection include HPV 
positive mother (with multiple HPV genotypes) during the time of delivery and 
vaginal delivery (Medeiros et al. 2005; Park et al. 2012; Hahn et al. 2013; Trottier 
et al. 2016). Still, not all studies have been able to identify specific parental risk-
factors for infant HPV transmission (Smith et al. 2007). There have been no studies 
examining the interactions between bacterial microbiota and oral HPV infection in 
the neonatal or infant oral cavity. The impact of neonatal oral HPV infection to later 
life also still remains to be clarified. 
2.4 Microbiome and cancer 
Cancer development is a complex process and numerous risk-factors have been 
detected to increase the risk for malignant transformation. The most important 
recognised risk-factors include carcinogens in various substances, such as in tobacco 
smoke and alcohol use. Ionising irradiation, genetic susceptibility and everyday 
mutations during normal cell division processes are all possible mechanisms for 
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acquiring severe mutations in a single cell. If the mutated cell is then able to pass all 
body’s regulators, which function to monitor normal cell division processes, there is 
a chance that it could proceed to cancer. Furthermore, viruses, such as HPV, Epstein-
Barr virus (EBV) and hepatitis B and C viruses (HBV and HCV) may induce cancer 
development. It has been estimated that viruses and bacteria cause 10-20% of all 
cancer (Zur Hausen 1991; De Martel et al. 2012; Khoury et al. 2013). 
Our knowledge regarding the impact of the bacterial microbiota to cancer 
development is increasing. Alterations in microbiota composition have been detected 
in various human cancer types, including colorectal cancer, pancreatic cancer, breast 
cancer and oral cancer. Especially the oral and gut microbiota have been detected to 
be implicated in this complicated issue. (Lu et al.; Schwabe and Jobin 2013; Wang 
and Ganly 2014; Michaud and Izard 2014; Zitvogel et al. 2015; Garrett 2015; Chen, 
Domingue and Sears 2017; Zhao et al. 2017; Lee et al. 2017; Mani 2017; Rajagopala 
et al. 2017; Flemer et al. 2018; Healy and Moran 2019).  
One possible mechanism behind this is that certain pathogenic bacteria and 
general dysbiosis of the microbiota might induce an inflammatory response and the 
formation of toxic metabolites which, after a significant duration, could induce 
carcinogenesis and cancer development (Brennan and Garrett 2016; Lucas, Barnich 
and Nguyen 2017; Nieminen et al. 2018). The underlying mechanisms are very 
complex and difficult to study, given the complexity of cancer development in 
general and the fact that multiple simultaneous mechanisms are often required in 
order for the cancer to develop. Research have mainly been able to make cross-
sectional studies in human study populations, while the causal relationship remains 
unclear. Furthermore, cancer itself might be able to cause dysbiosis. (Steed and 
Stappenbeck 2014; Healy and Moran 2019).   
When treating patients with cancer, surgery, radiotherapy and cytostatic drugs 
are the main choices of treatment. Previously, there was suggestions that HPV 
positive carcinomas, especially in the head-and-neck region, could become more 
aggressive after radiation treatment (Majoros, Devine and Parkhill 1963; Zehnder 
and Lyons 1975; Bauman and Smith 1996; Blackledge and Anand 2000). On the 
contrary, more recent studies have detected higher radiosensitivity in HPV positive 
carcinoma patients with HNSCC and cervical squamous cell carcinoma (CSCC) 
(Harima et al. 2002; Kimple et al. 2013; Zhang et al. 2015). It is shown that HPV 
positive OPSCC patients have longer life-expectancy and better prognosis than 
patients with HPV negative OPSCCs (Ang et al. 2010; Kimple et al. 2013; Zhang et 
al. 2015; Li et al. 2017a). Still, not all the studies have corroborated these findings 
(Nagel et al. 2013; Schneider, Bol and Grégoire 2017). On the other hand, CSCC 
patients positive with multiple simultaneous HPV genotypes have poorer overall 
prognosis compared to CSCC with single HPV type (Bachtiary et al. 2002). 
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3 Aims of the Study 
The present study focuses on understanding how the microbiota and present HPV 
infection interact with each other in the maternal oral cavity and uterine cervix, 
placenta, and breast milk and in the infant oral cavity. Furthermore, we aimed to 
investigate the presence of bacterial DNA from placenta samples to evaluate whether 
the placenta might harbour a bacterial microbiota. Finally, the HPV positive cell 
behaviour and invasion into the human uterine extracellular leiomyoma-based 
matrix was evaluated. 
 
The specific study aims were: 
1. To investigate the bacterial microbiota composition in the maternal oral 
cavity, uterine cervix, placenta, and breast milk as well as in the infant oral 
cavity. 
2. To study the associations between HPV and microbiota composition at the 
same body sites. 
3. To understand how maternal microbiota from the oral cavity, cervix and 
placenta influence the initial neonatal oral cavity microbiota. 
4. To see how HPV positive cell lines (SiHa and CaSki) behave in novel cultures 
of myoma invasion assay and Myogel Transwell invasion assay and how 
irradiation and different HPV copy numbers affect to cell invasion. 
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4 Materials and Methods 
4.1 Subjects and materials 
4.1.1 The Finnish Family HPV Study (I, II, III) 
The samples in the studies I-III are derived from the longitudinal Finnish Family 
HPV study (Syrjänen et al. 2009; Rautava et al. 2012a). The samples were collected 
during the years 1998-2001 at the Department of Oral Pathology, Institute of 
Dentistry, University of Turku and the Department of Obstetrics and Gynaecology, 
Turku University Hospital, Finland. The original study was designed to evaluate the 
interactions of HPV infection between families; mothers, fathers and their infants. 
In total, 329 mothers were enrolled in their last trimester of their first pregnancy. 
The participating women gave birth to 331 infants (two sets of twins were born). In 
addition, 131 fathers were enrolled. The study protocol and its amendments were 
approved by the Research Ethics Committee of the Intermunicipal Hospital District 
of Southwest Finland (#3/1998, #2/2006, 45/180/2010). Written informed consent 
was obtained from all participants of the original Finnish Family HPV Study. 
4.1.2 Biological samples (I, II, III) 
A total of 39 mothers were selected for the studies (I-III) based on the placental HPV 
status. Altogether, from the entire Finnish family HPV study, 13 placentas out of 329 
were detected positive for HPV DNA and were selected as cases. The HPV infection 
in the placenta was earlier confirmed with In Situ Hybridisation (Sarkola et al. 
2008a). The placenta controls were selected based on the availability of samples and 
the mode of delivery (26 placenta controls; 13 from vaginal deliveries and 13 from 
caesarean section). In total we worked with 39 placenta samples from the original 
Finnish Family HPV study. In the bacterial microbiota analyses, however, we were 
forced to exclude a number of placenta samples because low number of reads. At the 
end 49.0% (n=19/39) of high-quality placenta samples (of which vaginally delivered 
52.6%, n=10/19) were included in the microbial analyses. 
In study I, in addition to the placenta samples, the corresponding oral and 
cervical samples (n=39) from these women were analysed. For the second (II) study, 
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the corresponding neonates’ oral samples (n=40) were analysed in addition to breast 
milk samples (n=39) from the mothers. Five samples from infant oral and four breast 
milk samples had to be excluded from bacterial analyses, because of poor DNA 
quality of the original sample.  
For the third study (III), we continued to work with the same mother and neonate 
pairs but selected the subjects from whom all four following samples were available: 
maternal oral cavity, uterine cervix, placenta and neonatal oral samples collected 
directly after delivery. Altogether eight mother-infant pairs were selected for the 
third study.  
The samples used in studies I-III are presented in Table 5. Also, the infant sex, 
the duration of the gestation and the delivery mode are listed. 
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Table 5. The samples used in the microbiota studies (I, II, III). 
No/family 
Infant sex 
(B boy, 
G girl) 
Delivery mode 
(V vaginal, 
C caesarean section) 
Gestation 
weeks 
Study 
number 
1 G V 42.0 I, II** 
2 G V 41.0 I, II, III 
3 G C 35.4 I, II** 
4 G V 40.1 I, II 
5 B V 37.6 I, II 
6 G V 40.1 I, II 
7 B V 42.0 I, II 
8 G V 39.4 I, II 
9 G V 38.3 I, II*** 
10* B V 38.0 I, II 
11* B V 38.0 I, II 
12 B C 38.5 I, II 
13 B C 42.2 I, II 
14 G V 41.5 I, II 
15 B V 41.0 I, II 
16 B V 39.0 I, II 
17 G C 40.0 I, II, III 
18 B C 42.1 I, II 
19 G C 42.4 I, II 
20 G C 41.1 I, II 
21 G V 39.6 I, II 
22 B C 38.4 I, II***, III 
23 G V 39.0 I, II** 
24 B V 42.0 I, II, III 
25 G V 40.4 I, II, III 
26 G C 39.0 I, II 
27 B V 40.4 I, II, III 
28 G V 41.0 I, II 
29 G C 39.1 I, II 
30 G V 41.6 I, II 
31 G C 40.6 I, II 
32 B V 38.3 I, II, III 
33 G V 40.6 I, II 
34 G V 40.0 I, II, III 
35 G C 39.0 I, II, III 
36 G C 41.4 I, II***, III 
37 B V 39.6 I, II** 
38 B C 35.3 I, II***, III 
39 B V 36.6 I, II** 
40 B C 42.0 I, II, III 
* twins, **infant oral sample not included, ***breast milk sample not included 
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4.1.3 Collection of the samples (I, II, III) 
Oral samples 
Oral samples from the mothers and neonates were collected as mucosal scrapings 
with a small brush (Cytobrush, MedScan, Malmö, Sweden). A swab was taken from 
both cheeks and the superior and interior buccal vestibule with three to four gentle 
back-and-forth scrapes. Maternal oral sample was obtained during the third trimester 
of the pregnancy. Neonatal oral samples were collected directly after delivery or at 
two months of age. Brushes were placed in a tube containing 70% ethanol and frozen 
to -80°C until used. 
Cervical samples  
The cervical scrapings were taken with a brush (Cytobrush, MedScan, Malmö, 
Sweden) during the third trimester and the brush was then placed in a tube containing 
0.05 M PBS (phosphate buffered saline) with 100 μg of gentamycin and stored at  
-80°C until analysed. 
Placenta samples  
Placenta samples were tissue samples obtained directly after the delivery in the 
delivery room and included all the tissue layers from the central part of maternal side 
of the placenta. The samples were around 1 cm in diameter and were stored at -80°C 
until analyses. 
Breast milk samples  
The breast milk samples were obtained by the mothers themselves manually 
separately from feeding and after careful hand disinfection. No nipple disinfectant 
was used before sample collection and the procedure was done apart from feeding 
the infant. Samples were collected after the delivery or two months postpartum from 
the first proportion of the breast milk. Time when the samples were collected varied 
between individuals. The milk was collected into 3 ml sterile plastic containers, 
sealed and stored at -70°C until used. 
4.1.4 Cell lines in 3D extracellular matrix cultures (IV) 
Commercially available uterine cervix HPV positive SCC cell lines SiHa (ATCC® 
HTB-35™) (LGC Standards GmbH, Wesel, Germany) and CaSki (ATCC® CRL-
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1550™) (LGC Standards GmbH, Wesel, Germany) were used in addition with HPV 
negative human oral tongue SCC cell line HSC-3 (JCRB 0623; Osaka National 
Institute of Health Sciences, Osaka, Japan) for cell cultivations. CaSki contains 
approximately 600 HPV viral copies per cell, while SiHa only one to two HPV 
copies (Yee et al. 1985; Raybould et al. 2014). HSC-3 cells were used as a control.  
4.2 Methods 
4.2.1 DNA extraction (I, II, III) 
Oral, cervical and placenta samples 
DNA was extracted from the brush samples (oral and cervical scrapings) and from 
placenta tissue with the high-salt method (Miller et al. 1988). A piece of frozen 
placenta was grounded into pieces with a cutter on ice before starting the lysis. A 
lysis buffer (10 mM Tris, 400 mM NaCl, 100 mM EDTA, 1% SDS) was used to lyse 
the samples. This was followed by digestion with proteinase K (10 μl/ml) in +37°C 
overnight. Proteins were precipitated with saturated NaCl and ethanol. DNA was 
then dissolved in 50 μl water, mixed for 30 minutes and stored at -70°C until used.  
Breast milk samples 
DNA was extracted from milk samples by using high pure PCR template preparation 
kit (Roche Diagnostics GmbH, Penzberg, Germany). The samples were centrifuged 
at 12.000 rpm for 5 minutes for the pellet to format, followed by lysis with proteinase 
K in Tissue lysis buffer at 55°C for 1 hour. The lysis was then applied to a filter tube 
and passaged through a glass fleece with centrifugation. Residual impurities were 
removed with wash-and-spin steps. All purified DNA samples were stored at -70°C. 
4.2.2 HPV detection (I, II) 
DNA extraction 
Nested PCR with external (MY09/MY11) and internal (GP05+/GP06+) primers 
were used to detect HPV DNA from oral, placental and breast milk samples. For 
cervical samples, only single PCR with GP05+/GP06+ primers were used. A 50 μg 
reaction mixture was used with Amplitag Gold DNA polymerase (Perkin Elmer, NJ, 
USA). The sensitivity of the PCR method was around 20 copies of HPV. 
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HPV genotyping 
Genotyping was performed by using the fluorescent bead array of the Multimetrix 
assay (Progen Biotechnik GmbH, Heidelberg, Germany), which detects 24 HPV 
types (LR-HPV6, 11, 42, 43, 44, and 70; HR-HPV16, 18, 26, 31, 33, 35, 39, 45, 51, 
52, 53, 56, 58, 59, 66, 68, 73 and 82 types). The test was performed according to 
manufacturers’ instructions except the nested PCR products were re-amplified for 
biotinylation using GP05+/GP06+ primers and only half of the recommended 
volume, but in the final step, 100 μl of the blocking buffer was used. Hybridized 
beads were measuring with a Luminex LX-100 analyser (Bio-Plex 200 system, Bio-
Rad Laboratories, Hercules, USA) (Figure 9). The median fluorescence intensity 
(MFI) of at least 100 beads was computed for each bead in the sample. The cut-off 
value for each HPV probe was defined individually; 1.5x negative control MFI 
(background) +5 MFI.  
The samples detected positive for HPV16 were re-analysed from the original 
sample with nested PCR and with internal and external primers, in addition with 
bead based HPV16 genotyping assay. This additional step was done in order to 
control any possible contamination of HPV16 during previous testing. Other 
possible contamination of tested samples was controlled by the simultaneous 
analysis of HPV negative control samples with each run. 
 
Figure 9.  The bead-based multiplex HPV genotyping (Luminex) assay. (Schmitt et al. 2006) 
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4.2.3 Microbiota analysis (I, II, III) 
After the total DNA extraction, the isolated double-stranded DNA concentrations 
were evaluated and quantified with Qubit® 2.0 Fluorometer (Life Technology, 
Carlsbad, CA, USA). Working solution was prepared mixing Qubit® reagent 1:200 
to Qubit® buffer. All samples were normalized to 10 ng/μl prior to 16S rRNA gene 
sequencing with Illumina MiSeq Platform.  
The V3-V4 region of the 16S rDNA bacterial gene was amplified with PCR 
using Illumina adapter overhang nucleotide sequences following the Illumina 
protocols. After the 16S rDNA gene amplification, the multiplexing step was 
conducted using Nextera XT Index Kit (Illumina, San Diego, CA, USA) to construct 
DNA libraries. PCR products were checked in Bioanalyzer DNA 1.000 chip (Agilent 
Technologies, Santa Clara, CA, USA). Libraries were sequenced using 2x300 bp 
pair-end run (MiSeq Reagent Kit V3) on a MiSeq Illumina platform (Lifesequencing 
sequencing service, Valencia, Spain). The schematic illustration of the V3-V4 
detection is presented in Figure 10.  
To rule out any possible contaminants, PCR amplifications and library kit 
controls were sequenced along each run as negative controls. Strict quality control 
was carried out when working with low bacterial biomass, placenta and infant oral 
samples, in particular. Before microbiota analyses, all possible contaminants were 
removed: single OTUs, OTUs with relative frequency below 0.01, sequences that 
could not be classified to domain level and Cyanobacteria, Chloroplasts and 
Rhizobiales were all removed.  
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Figure 10. Schematic view of Illumina platform workflow. Libraries are normalized, pooled and 
sequenced on the MiSeq system by using v3 reagents. Figure from the Illumina 16S 
Metagenomic Sequencing Library Preparation protocol. 
4.2.4 Myoma and Myogel (IV)  
Three-dimensional cancer cell behaviour modelling has been used for some ten 
years. Myoma invasion assay and Myogel Transwell assay have been developed in 
the University of Oulu by Professor Salo’s research group (Nurmenniemi et al. 2009; 
Salo et al. 2015).  
Myoma is a benign tumour derived from monoclonal smooth muscle cells and 
arises in the uterine wall. These tumours are mainly composed of extracellular 
matrix, including collagen, fibronectin and proteoglycan. Myomas are quite common 
affecting more than half of women worldwide and they do not have potential to 
develop into malignant tumours over time. In most of the cases, they do not present 
any symptoms. If symptoms such as abdominal pain or over-excessive (menstrual) 
bleeding occur, the myomas may be removed surgically (Parker 2007; Tinelli et al. 
2016). The myoma specimens for the assays have been obtained during routine 
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surgical procedures and the studies have been approved by the Northern 
Ostrobothnia Hospital District Ethics Committee (statement #8/2006, amendment 
19/10/2006 and statement #35/2014, 28.4.2014).  Myogel has been derived from 
myomas. 
With the myoma model, all the normal extracellular components are maintained 
(e.g. vessels, collagen fibres and soluble factors, including cytokines and growth 
factors) and the cell behaviour is not influenced by foreign materials (Nurmenniemi 
et al. 2009; Dayan et al. 2012; Teppo et al. 2013; Alahuhta et al. 2015; Al-Samadi 
et al. 2017; Naakka et al. 2019). Even though the myoma discs provide an excellent 
hypoxic, human tumour derived three-dimensional solid platform to study cancer 
cells behaviour in vitro, it is essential to keep in mind that human body has several 
other factors, such as blood derived cells and cytokines, that affect cancer cell 
aggressiveness in vivo.  
Another myoma derived matrix, Myogel, has been designed for gel-based 
attachment, transwell and spheroid invasion assays (Nurmenniemi et al. 2009; Salo 
et al. 2015, 2018; Sundquist et al. 2016; Åström et al. 2018). These novel matrices 
help us to extend our knowledge of carcinoma cell invasion in vitro, in order to 
understand carcinoma cell behaviour in vivo. 
Myoma discs preparation 
Myoma tissue preparation has been described in detail previously (Nurmenniemi et 
al. 2009). Briefly, all myomas were visually evaluated to discard any defected 
myomas. The samples were cut out from 3 mm thick slices with 8 mm biopsy punch 
(Kai Industries Co., Gifu, Japan) and placed in media with 10% DMSO solution in  
-70°C for later use.  
Myogel preparation 
Myogel has been derived from myoma (Salo et al. 2015). The liquid nitrogen frozen 
myoma section were grounded to powder with CryoMill (Retsch, Haan, Germany) 
and a 10 g of tissue powder was then suspended to 20 ml of cold NaCl buffer (3.4 
M, pH 7.4) followed by centrifugation. To homogenize the pellet, 20 ml of the same 
NaCl buffer with T18 Ultra-Turrax (IKA®-Werke GmbH & Co. KG, Staufen, 
Germany) was added. Protein concentration was measured with DC Protein Assay 
(Bio-Rad) and the absorbance at 590 nm with Victor3V 1420 Multilabel Counter 
and Wallac 1420 Manager (Perkin Elmer Life and Analytical Sciences, Turku, 
Finland). The Myogel solution was stored in -20°C for later use. 
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4.2.5 Cell cultures (IV) 
Cell culture 
The SiHa and CaSki were cultivated in DMEM with 10% heat-inactivated foetal 
bovine serum (FBS), 100 U/ml penicillin, 100 μl/ml streptomycin and 1% non-
essential amino acids (all from Gibco, Life Technologies, Paisley, UK). HSC-3 cells 
had a different media, which consisted of DMEM/F-12 (1:1) with 10% FBS, 100 
U/ml penicillin, 100 μl/ml streptomycin (Gibco, Life Technologies, Paisley, UK) in 
addition with 4 mg/ml Hydrocortisone, 50 μg/ml Ascorbic Acid (vitamin C) and 250 
ng/ml Fungizone (Sigma-Aldrich, Ayrshire, UK). SiHa and CaSki were cultured in 
normal DMEM-media. For HSC-3 cells 1:1 DMEM/F-12 was used.  
Myoma invasion assay 
To prepare the cultures, the myomas were thawed to room temperature and washed 
with appropriate media. Myoma discs were placed in sterile tubes with 10 ml media 
to wash overnight. After 24 h myomas were carefully placed in a 24-well Transwell 
inserts (Corning #3422, membrane diameter, 6.5 mm, pore size 8.0 μm; Corning, 
Inc., Corning, NY) avoiding breaking the myoma tissue. Around 750.000 cells in 
50 μl media were added on top of each myoma disc. Lower chamber of the well was 
filled with 500 μl appropriate cell culture media. Cells were incubated and allowed 
to attach and grow for 24 h in +37°C.  
The myoma discs were carefully removed from the inserts and placed in 12-well 
culture plate on top of metal grid and uncoated nylon membrane with 1.000 μl media 
in the bottom of the well. It was important to notice, that the grid and the membrane 
were in contact with the media and no air bubbles were left under the grid. The cells 
were allowed to invade altogether for 14 days. The cell culture media was changed 
in every three to four days. Figure 11 presents the Myoma invasion model in 
schematic overview. 
The culture was finished after day 14 and the tissues were prepared for histology 
by fixing with 4% formalin overnight. The specimens were then dehydrated, cut in 
half and embedded in paraffin. Six μm sections were deparaffinised and stained with 
haematoxylin-eosin (HE) to estimate the overall success of the cell cultures and then 
with cytokeratin (Cytokeratin High Molecular Weight, Clone 34BE12 or 
Pancytokeratin, Clone AE1/AE3, Dako, Clostrup, Denmark) to detect epithelial cells 
and to analyse cell invasion depth and invasion area. The results, performed in 
triplicate, represent an average of two to six independent cultures.  
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Irradiation of myomas 
A part of the myomas (one 12-well plate) were irradiated with Faxitron MultiRad350 
(DatekMedíco, Aarhus, Denmark) irradiator according to the manufacturer’s 
instructions in order to give the cells ionized radiation equivalent to 4 Gy on the third 
day of cultivation. The 4 Gy radiation dose is the smallest amount of ionised 
radiation given in a single dose with visible effects to cell invasion (Väyrynen et al. 
2018). Also, one 12-well plate was mock-irradiated simultaneously and carried along 
but did not receive any radiation.  
 
Figure 11.  Schematic overview of the Myoma invasion model. Figure modified from the myoma 
Transwell invasion protocol manual. 
Myogel Transwell invasion assay  
Myogel mix of 0.8 mg/ml rat collagen and 2.4 mg/ml Myogel was prepared on ice. 
A volume of 50 μl of this Myogel mix was used to coat 24-well Transwell inserts, 
followed by 30 minutes to 1-hour incubation at +37°C for the gel to develop. To the 
bottom of each well, 500 μl of normal cell culture media (according to the cell line 
used) was added. Total of 70.000 cells in 200 μl lactalbumin media were added on 
top of Myogel. In lactalbumin media, the FBS was replaced by 0.5% lactalbumin 
(Sigma-Aldrich, Ayrshire, UK).  
The cells were allowed to grow and invade for 72 h and then fixated with 4% 
paraformaldehyde for 1 h. Paraformaldehyde was collected to waist container and 
cells were washed once with 500 μl PBS. The bottom of the well and the Myogel 
from the insert were drawn empty. Invaded cells were stained with 1% Toluidine 
blue + 1% Borax at room temperature for 10 minutes. After staining, the cells were 
washed several times with distilled water and non-invaded cells from the upper 
chamber of the inserts were carefully removed with wet cotton swabs.  
Staining was eluted with 500 μl 1% SDS. The eluted solution was transferred to 
three wells on 96-well plate, 150 μl to each well. The absorbance was measured at 
Carcinoma 
cells 
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650 nm using MTT assay with Synergy™ HT (BioTek Instruments Inc., Winooski, 
Vermont, USA) according to the manufacturer’s instructions. The results represent 
an average of three cultures, performed in triplicate. 
4.2.6 Bioinformatics and statistical analyses 
Microbiota studies (I, II, III)  
After primal removal, FASTQ files with sequences less than 300 nucleotides read 
length or with quality less than Q20 were trimmed and quality filtered by using the 
Fastx tool kit version 0.0134. Once the sequences were cleaned based on quality 
scores, we trimmed traces of the 16S rRNA primers and sequencing adapters using 
cutadapt version 1.2.5. After primer removal, sequences with <300 nucleotides read 
length were trimmed using pearl scripting. Sequences were mapped against the 
human genome BWA version 0.7.1 (Li and Durbin 2010) and filtered with samtools 
version 1.3.1–50. The clean FASTQ files were converted to FASTA files and 
chimeric sequences were removed by using UCHIME program version 4.2. (Edgar 
et al. 2011). 
An open reference Operational Taxonomical Units (OTU) picking method using 
97% (I) -99% (II, III) identity to the Greengenes 13_8 database was performed using 
QIIME pipeline (version 1.9.0) (Caporaso et al. 2010). Singletons and OTUs with a 
relative abundance below 0.01 were removed. Also, sequences that could not be 
classified to domain level, or were classified as Cyanobacteria, Chloroplasts (as they 
likely represent cellulose and cotton material) and Rhizobiales (as potential 
environmental contaminants) were removed from the dataset.  
Alpha diversity indices for Chao1 (species richness) and Shannon (species 
diversity) in addition with beta diversity using UNIFRAC (phylogenetic) and Bray 
Curtis distance (non-phylogenetic) were used for microbiota analyses. The analysis 
of Similarities (ANOSIM) test was used to detect statistically significant differences 
between the different groups. Calypso software version 8.10 (I) or 8.24 (II, III) 
(http://cgenome.net/calypso/) was used with total sum normalization (TSS) for the 
statistical analyses and Cumulative Sum Scaling normalization (CSS) for 
multivariate tests (Redundancy Analysis - RDA). Linear discriminant analysis effect 
size (LEfSe) was used to detect unique biomarkers (linear discriminant analysis 
(LDA) score > 3.0) in relative abundance of bacterial taxonomy. Inter- and 
intraindividual variability was detected by pair-level analyses (paired t-test). 
SourceTracker 1.0.1 with QIIME1 was used to analyse the contribution of 
microbiota from different body sites to neonatal oral cavity microbiota. PcoA and 
RDA analyses were used to depict interactions between different bacterial 
microbiota groups. PCoA analysis is a mathematical method, which detects 
Materials and Methods 
 51 
similarities or dissimilarities in a given data set with multiple different groups 
studied at the same time. PCoA utilises a distance matrix, takes into account the 
composition and abundance and provides a three-dimensional figure to visualise the 
interactions. On the other hand, RDA is a multivariate analysis and assumes linear 
relationships and provides p-values in addition to visualisation. P-values ≤ 0.05 were 
considered statistically significant.  
Cell cultivation study (IV)  
Analyses were performed with Fiji software ImageJ 1.52a (National Institute of 
Health, USA) (Åström et al. 2018). The statistical analyses were all performed with 
IBM SPSS (SPSS for Windows, version 22.0.0.1, SPSS Inc., Chicago, IL, USA). 
After checking the normality distribution of all the samples, either the independent 
samples Student’s T-test or Mann-Whitney U-test was used for unrelated samples. 
If the samples were related, paired samples T-test or Wilcoxon signed-rank test was 
used. Again, p-values ≤ 0.05 were considered statistically significant.  
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5 Results 
5.1 HPV DNA detection (I, II) 
From the entire Finnish Family HPV Study, a total of thirteen HPV positive 
placentas were found (3.9% = 13/330). These subjects were selected as the basis of 
our work and 26 subjects with HPV negative placentas were selected as controls. 
When the HPV status of the samples from other anatomical sites and the infants’ oral 
cavity in the study population were examined, HPV was detected in 33.3% maternal 
oral cavity samples, 23.1% of the cervical samples, 8.6% of the breast milk samples 
and 40.0% of the infant oral cavity samples. The most predominant genotypes were 
HPV16 (17.9%) in the maternal oral cavity, multiple genotypes (12.8%) in the 
cervix, HPV16 (17.9%) in the placenta, HPV6 (5.7%) in breast milk and HPV16 
(14.3%) in the infant’s oral cavity. Multiple simultaneous HPV infections were 
discovered in 7.7% maternal oral, 12.8% cervical and 2.9% infant oral cavity 
samples. Only the placenta and breast milk did not present with simultaneous 
multiple HPV infections. Detailed information of HPV positive samples, in addition 
with the detected HPV genotypes, is presented at Table 6. 
Table 6. HPV genotype distribution among all of the samples studied. 
 HPV 
genotype/s 
Mother oral 
(n=39) 
Cervix 
(n=39) 
Placenta 
(n=39) 
Breast milk 
(n=35) 
Infant oral 
(n=35) 
H
R
- H
PV
 HPV 16 7 (17.9%) 2 (5.1%) 7 (17.9%) 1 (2.9%) 5 (14.3%) 
HPV 18 - - - - 2 (5.7%) 
HPV 58 - - - - 1 (2.9%) 
HPV 66 1 (2.6%) - - - 2 (5.7%) 
LR
-H
PV
 HPV 6 1 (2.6%) 2 (5.1%) 5 (12.8%) 2 (5.7%) 1 (2.9%) 
HPV 11 1 (2.6%) - - - - 
HPV 83 - - 1 (2.6%) - - 
HPV 70 - - - - 1 (2.9%) 
 multiple types 3 (7.7%) 5 (12.8%) - - 1 (2.9%) 
 Total 
HPV +ve 
13/39 
(33.3%) 
9/39 
(23.1%) 
13/39 
(33.3%) 
3/35 
(8.6%) 
13/35 
(37.1%) 
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None of the mother-infant pairs were HPV positive in all of the five body sites 
simultaneously. One mother-infant pair was HPV16 positive at the same time in four 
locations (mother oral cavity, cervix, placenta and infant oral cavity). One additional 
pair was HP16 positive in three locations simultaneously (mother cervix, placenta 
and infant oral cavity) and one mother had HPV6 in her oral cavity, cervix and 
placenta at the same time, but her infant was born HPV negative in his oral cavity. 
Altogether, 13 mother-infant pairs were completely HPV negative from all the 
different body sites investigated at the time of the sample collection. 
5.2 Bacterial DNA detection (I, II, III) 
We detected different amounts of bacterial DNA in the different anatomic sites 
studied. The cervical samples had the highest amount of DNA, on average 86.609 
reads per sample, followed by the maternal oral cavity (80.470 reads), infant oral 
cavity (62.312 reads), breast milk (46.356 reads) and placenta with 36.268 reads. 
The proportional volume of the 16S rRNA gene copies per ng of DNA is presented 
in Figure 12. 
 
Figure 12. The copy numbers per nanograms (ng) DNA from all of the samples studied. 
NTC=negative PCR controls from the study. 
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5.3 The bacterial microbiota composition at 
different body sites (I, II, III) 
The bacterial microbiota compositions from all the anatomical sites irrespective of 
HPV status are presented at phylum level in Figure 13. The most abundant phyla 
were similar at all the studied anatomical sites, with Firmicutes exhibiting highest 
relative abundance, followed by Proteobacteria, Actinobacteria and Bacteroidetes. 
The different body sites represented unique composition when examined at family 
level (Figure 14). 
 
Figure 13. The bacterial microbiota compositions at phylum level. Mother oral, cervix, 
placenta, breast milk and infant oral cavity were consistent with each other as Firmicutes 
presented as the most abundant family followed by Proteobacteria and Actinobacteria. 
The results on the placenta microbiota from both delivery modes have been merged 
together. 
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Figure 14. The bacterial distribution at the different groups according to family level. The top 
21 most abundant families are presented in each group. The results on the placenta 
microbiota from both delivery modes have been merged together. 
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Maternal oral cavity 
At phylum level, the maternal oral cavity harboured Firmicutes (33.7%), 
Proteobacteria (21.4%), Actinobacteria (15.4%) and Bacteroidetes (13.7%). The 
most abundant families in the maternal oral cavity were Streptococcaceae (15.0%), 
Pasteurellaceae (9.2%) and Veillonellaceae (8.8%). 
Cervix 
The most abundant phylum in the uterine cervix was Firmicutes (79.3%), followed 
by Bacteroidetes (13.0%), Actinobacteria (10.9%) and Proteobacteria (1.4%). 
Lactobacillaceae (69.2%) were the predominant family in cervical samples, 
followed by small amounts of Bifidobacteriaceae (8.9%) and Veillonellaceae 
(3.0%).  
Placenta 
The most abundant phyla in the placenta were Proteobacteria (33.9%), Firmicutes 
(33.5%), Actinobacteria (18.4%) and Bacteroidetes (9.0%). The main families were 
Comamonadaceae (14.4%), Staphylococcaceae (6.9%) and Bifidobacteriaceae 
(6.2%).  
Breast milk 
The most abundant phyla in breast milk were Firmicutes (60.3%), Proteobacteria 
(20.3%), Actinobacteria (14.0%) and Bacteroidetes (3.5%), which constituted more 
than 90% of the bacteria detected in milk. More than 50% of the families were 
composed from Streptococcaceae (26.7%), Gemellaceae (12.8%) and 
Staphylococcaceae (10.4%).  
Infant oral cavity 
Infant oral cavity also harboured Firmicutes (53.7%), as the most abundant phylum, 
followed by Actinobacteria (16.4%), Proteobacteria (14.0%) and Bacteroidetes 
(11.7%). The predominant families were Streptococcaceae (24.7%), 
Micrococcaceae (6.2%) and Veillonellaceae (5.6%).  
At genus level, eight genera we detected to be shared between the groups (Figure 
15). The core microbiota consisted of Streptococcus, Staphylococcus, Pseudomonas, 
Prevotella, Lactobacillus, Delftia, Corynebacterium and Unclassified.  
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Figure 15. Core microbiota at genus level. A total of eight genera were detected to be shared 
between the five different groups studied. 
5.4 The impact of delivery mode to microbiota 
composition (I, II, III) 
We did not detect any association between the mode of delivery and the bacterial 
composition at any of the anatomical sites. As per PCoA and RDA (p-values shown) 
analyses, the maternal oral cavity (p=0.685), cervix (p=0.880), placenta (p=0.316), 
breast milk (p=0.942) and infant oral cavity (p=0.565) bacterial microbiota were all 
did not affect by the delivery mode in this study.  
5.5 HPV and microbiota interactions (I, II) 
Maternal oral cavity 
Bacterial microbiota richness (Chao1, p=0.0319) was higher in HPV positive 
(33.3%, n=13/39) maternal oral samples as compared to HPV negative samples 
(publication I, Figure 3A). No differences in microbiota diversity were observed 
between the groups as assessed by the Shannon index (publication I, Figure 3B). 
Saccharibacteria (formerly known as TM7) was more abundant (p=0.026) at 
phylum level and TM73 (p=0.011), Selenomonas spp. (p=0.0032) and 
Megasphaera spp. (p=0.026) were more abundant at family level in the HPV 
positive samples. Furthermore, TM73 (p=0.018) at species level was increased in 
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HPV positive maternal oral samples. In the HPV negative samples, levels of 
Haemophilus spp. (p=0.019) were higher when compared with HPV positive 
group. With the LEfSe test, the genera unclassified Bifidobacteriaceae and 
Finegoldia were enriched in the HPV positive samples (LDA score > 3.36 and 3.32 
respectively, p<0.05) and Haemophilus genus in the HPV negative group 
(publication I, Figure 3E).  
Cervix 
Our samples consisted of 23.1% HPV positive cervical samples (n=9/39). No 
statistically significant differences were observed in the species richness or diversity 
according to HPV status in the cervical samples (publication I, Figures 2A and 2B). 
Peptostreptococcaceae (p=0.0065), Enterococcaceae (p=0.022), Haemophilus 
(p=0.00058) and Peptostreptococcus (p=0.0069) were all significantly more 
abundant in HPV negative cervical samples. Coriobacteriaceae (p=0.083) and 
unclassified Coriobacteriaceae (p=0.07) appeared to be slightly increased in the 
HPV positive group without statistical correlation. In the LEfSe test, unclassified 
Coriobacteriaceae (LDA score>4.40, p<0.05), and more precisely Atopobium 
vaginae, was enriched in the HPV positive group and Haemophilus (LDA 
score>4.18, p<0.05) in the HPV negative cervical samples as compared to HPV 
positive samples (publication I, Figure 2E).   
Placenta 
Placenta microbiota diversity and richness exhibited no differences according to 
HPV status (31.6% HPV positive placenta samples analysed by bacterial microbiota 
composition, n=6/19) (publication I, Figures 1A and 1B). However, higher relative 
abundance of Lactobacillaceae (p=0.0036) and Lactobacillus genus (p=0.0023) 
were detected at HPV positive placenta samples (publication I, Figure 1E). The 
LEfSe test showed increased levels of Ureaplasma and Lactobacillus genus (LDA 
score>4.0, p<0.05) in the HPV positive placenta group compared to HPV negative 
samples (publication I, Figure 1F).  
Breast milk 
Only three breast milk samples (n=3/35) were positive for HPV (8.6%) and 
consequently, the bacterial microbiota differences between the HPV positive and 
negative samples could not be analysed due to the insufficient sample size.   
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Infant oral cavity 
No differences in microbiota diversity or richness were observed between the HPV 
negative and positive samples (37.1% HPV positive samples, n=13/35; publication 
II, Figures 5A and 5B). Veillonella (p=0.025) and Veillonella dispar (p=0.048) were 
more abundant in HPV negative samples. In HPV positive samples, we observed 
more Propionibacteriaceae (p=0.095), Propiobacterium (p=0.095) and 
Propionibacterium acnes (p=0.093) than in HPV negative infant oral samples but 
the differences did not reach statistical significance. In LEfSe analyses, 
Lysinibacillus and Ureaplasma (LDA score>4.0, p<0.05) were enriched in the HPV 
positive samples and Veillonella (LDA score>4.0, p<0.05) was more abundant in the 
HPV negative group (publication II, Figure 5F). 
5.6 The contribution of maternal microbiota to the 
initial neonatal oral microbiota (III) 
The initial neonatal oral microbiota directly after the delivery, resembled most 
closely the microbial profile detected in the placenta, followed by the cervical and 
maternal oral microbiota. As presented in the Network analyses at OTU levels 
(Figure 16), there were mainly connections between the infant oral microbiota and 
the microbes detected in the placenta. No such interactions were evident with the 
other maternal sites. Furthermore, the other anatomical body sites tended to cluster 
more independently and separately from the neonatal oral cavity samples. 
Furthermore, RDA analyses (Figure 17) corroborated these findings as the groups 
all tended to all cluster separately except for the placental and neonatal oral 
microbiota profiles (p=0.001). 
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Figure 16. Clustered groups are visible in Network analyses showing the connections 
between the samples. Infant oral cavity microbiota and microbes detected at placenta 
shows overlapping, while the other anatomical areas are more clustered separately from 
these two. 
 
Figure 17. RDA analyses depicting the interaction between the different microbiota profiles. 
Neonatal oral microbiota and the microbes detected from placenta are clustered 
together and overlapping, whereas mother oral cavity microbiota and the cervical 
microbiota are clearly clustered separately. 
Placenta 
Neonatal oral 
Cervix 
Mother oral 
Cervix 
Neonatal oral 
Mother oral 
Placenta 
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Although placental and neonatal oral microbiota clustered together, no statistical 
association was detected (p=0.075) (Figure 18 A) was observed in individual 
mother-infant pairs when compared to unrelated groups. The same was not detected 
between neonatal and mother oral cavities (B, p=0.83) or neonatal oral cavity and 
cervical microbiota (C, p=0.79). 
A                                                 B                                                   C 
                 
Figure 18. T-tests showing connections between two groups at the time. The microbiota in the 
placenta and neonatal oral cavity (A) appeared similar but no statistically significant 
results were observed between the mother-infant pairs compared to unrelated 
individuals. No connection between the mother-infant pairs were detected in the mother 
oral cavity and her neonates’ oral cavity (B) or the mother cervix and neonatal oral cavity 
(C). 
5.7 HPV positive cell lines SiHa and CaSki 
invasion in the Myoma and Myogel (IV) 
Myoma invasion assay 
All three cell lines were observed to invade the myoma model. The average invasion 
depths were 1.25 µm for HSC-3, 1.28 µm for SiHa and 0.91 µm for CaSki. The 
difference was significant (p=0.0001) between both the SiHa and HSC-3 (p=0.003) 
when compared to CaSki invasion depth. SiHa (less HPV) invaded clearly deeper 
than CaSki cells (more HPV) and HSC-3 invasion was more efficient than in CaSki. 
No difference between HSC-3 and SiHa invasion depth was observed. When 
compared, the HPV positive (SiHa and CaSki) cells together to the HPV negative 
HSC-3 cells, a slight significant difference in the invasion depth (p=0.048) was 
observed as HPV negative HSC-3 cells invaded better. 
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The invasion area reached to 86.2 mm2 HSC-3, 94.3 mm2 SiHa and 74.9 mm2 
CaSki. No significant differences in the invasion area between the cell lines was 
detected, nor were there any differences in the invasion area between HPV positive 
cervical cells and HPV negative oral cells. Furthermore, the invasion indexes were 
53.6% HSC-3, 21.3% SiHa and 30.0% CaSki. The invasion index was calculated by 
dividing the invasion area with the total area of epithelial cells. As seen by the 
differences between invasion area and invasion index, HSC-3 tend to invade better 
as the percentage is greater while SiHa produced thicker epithelium and fewer 
invasion islets.  
Cell invasion in Myogel 
All the cell lines were detected to invade through the Myogel mixture. The 
absorbance units for cell invasion were 0.32 HSC-3, 0.30 SiHa and 0.25 CaSki. No 
statistically significant differences were observed between the absorbance units of 
the different cell lines.   
5.8 The impact of irradiation to cell invasion (IV) 
Invasion was significantly reduced in all three cell lines after 4 Gy ionized radiation. 
The average invasion depths decreased from 1.25 µm to 0.66 µm with HSC-3 
(p=0.008), from 1.28 µm to 0.42 µm with SiHa (p=0.001) and from 0.91 µm to 0.50 
µm with CaSki (p=0.005) as shown in Figure 19. The irradiation affected more to 
the invasion depth of HPV positive cells (SiHa and CaSki) than HPV negative HSC-
3 (p=0.048). 
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Figure 19. The average invasion depths change after the 4Gy irradiation in HSC-3, SiHa and 
CaSki cell lines. The mock-radiated samples presented at 0 Gy bar and the 4 Gy 
ionized radiation administered at day 3 shows a significant reduction in cell invasion in 
all the cell lines (**p≤0.001, *p≤0.01). 
The invasion area was additionally affected by radiation. The average invasion area 
diminished from 86.2 mm2 to 32.1 mm2 with HSC-3, from 94.3 mm2 to 5.61 mm2 
with SiHa and from 74.9 mm2 to 3.90 mm2 with CaSki as depicted in Figure 20. No 
statistically significant differences were observed in the decrease on invasion area 
after radiation in any of the cell lines studied, nor did we detect any differences 
between the HPV positive and HPV negative cell invasion decrease after radiation. 
 
Figure 20. Decrease in the invasion are depicted as µm2 x104 in HSC-3, SiHa and CaSki. The 4Gy 
ionized radiation administered at day 3 shows a reduction in cell invasion area in HSC-3 and 
SiHa. Also, slight reduction is observed in CaSki, but not as statistically significant. 
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The invasion indexes also decreased after the ionized radiation. A reduction from 
53.3% to 29.5% was observed in HSC-3, from 21.3 % to 13.7 % in SiHa and from 
30.0 % to 26.5% in CaSki.  
5.9 HPV copy number impact to cell invasion (IV) 
In Myogel invasion assay, no differences between SiHa (less HPV) and CaSki (more 
HPV) were observed (p=0.963) in the invasion though Myogel mixture (publication 
IV, figure 2).  
SiHa invaded into the Myoma significantly better (p=0.0001) than CaSki when 
compared by invasion depths (publication IV, figure 3B). No differences were 
observed in the invasion area (p=0.310) between the two cell lines (publication IV, 
figure 3C). After ionising radiation, SiHa invasion depth decreased slightly more 
(p=0.013) than CaSki (Figure 19), but neither any differences were observed in the 
reduction of invasion area (p=0.222) (Figure 20).  
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6 Discussion 
In this study, we detected significant changes in the bacterial microbiota composition 
according to HPV status in the maternal and infant oral cavity, the uterine cervix and 
in the placenta. In the maternal oral cavity, HPV positivity was also connected to 
higher bacterial richness than HPV negative samples. The initial neonatal oral 
microbiota seems not to be affected by delivery mode and we detected the neonatal 
oral cavity microbiota to resemble mostly the bacteria detected from the placenta. 
To the authors’ best knowledge, we have been the first to show that the bacterial 
microbiota in the placenta and oral cavity exhibits differences depending on the HPV 
status. Furthermore, we showed in vitro that irradiation reduces cell invasion in a 
myoma model. 
6.1 HPV and microbiota interactions in women 
The oral cavity, uterine cervix and placenta exhibited differences in microbiota 
profiles according to HPV status. Only in breast milk samples, we did not detect any 
differences, but this may be due to low number of HPV positive samples.  
The adult oral cavity microbiota composition has previously been 
comprehensively investigated (Dewhirst et al. 2010; Kilian et al. 2016) but no 
information has been available on the interaction between the microbiota and HPV 
in the oral cavity. In the present study, adult female oral cavity bacterial microbiota 
was mainly composed of Actinobacteria, Bacteroidetes, Firmicutes, Streptococcus 
and Veillonella, which is in line with the earlier literature (Dewhirst et al. 2010; Huse 
et al. 2012; Wade 2013; Verma, Garg and Dubey 2018). The oral specimens positive 
for HPV presented higher bacterial richness, but no differences in bacterial diversity 
compared to HPV negative samples. We detected higher levels of 
Bifidobacteriaceae, Selenomonas and Megasphaera in HPV positive oral cavity 
samples and more Haemophilus in HPV negative samples.  
The homeostasis of different bacterial species is crucial for the overall oral 
health. Selenomonas and Megasphaera are well known oral pathogens which have 
been found in patients with aggressive periodontitis and in endodontic abscesses 
(Gonçalves et al. 2012; Cruz et al. 2015; George et al. 2016; Johansson et al. 2016). 
Selenomonas abundance has been reported to be increased in the oral cavity of 
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patients suffering from rheumatoid arthritis and systemic lupus erythematosus 
(Graves, Corrêa and Silva 2019). These changes in microbiota may thus affect oral 
health in general. It is not known whether HPV lays the foundation for oral 
microbiota to accumulate these pathogenic bacteria. Furthermore, it is possible that 
these known periodontal pathogens may, on the other hand, provide a favourable 
platform for acquiring HPV infection. Interestingly, we did not detect any highly 
aggressive pathogens linked to periodontal disease to be associated with HPV 
positivity in oral cavity (Table 3). As a limiting factor, we did not have the 
information about our patients’ oral hygiene status (dental caries, periodontal pocket 
depths, bleeding on probing (BOP) index) while analysing the bacterial microbiota 
data. When the Finnish Family HPV Study was first designed, factors that could have 
affected the bacterial microbiota analyses were not considered, since HPV and other 
viruses were the main focus of the research.  
Interactions between HPV and the bacterial microbiota have mainly been studied 
in the cervical region (Gillet et al. 2011; Brotman et al. 2014; Mitra et al. 2016). 
Lactobacillus is the dominant bacterial genus in the cervix and vagina (Nugent, 
Krohn and Hillier 1991; Ravel et al. 2011; Liu et al. 2013; MacIntyre et al. 2015). 
According to our study, Lactobacillus contributed up to 86.8% (HPV positive group) 
to 89.7% (HPV negative group) of the total bacterial community in the cervical 
samples. Differences according to HPV status were observed in the cervical 
microbiota. We observed that Coriobacteriaceae, mainly Atopobium vaginae, was 
more abundant in the HPV positive cervix. In contradiction to this, A. vaginae has 
previously been associated with HPV persistence and bacterial vaginosis (Jespers et 
al. 2012; Mendes-Soares et al. 2015; Mitra et al. 2016; Di Paola et al. 2017).  
HPV infection incidence in the cervical region is highly variable ranging 
between 18.9% - 75% depending on geographical differences and other risk-factors, 
such as unprotected sexual intercourse, young age at sexual onset, multiple partners 
and general bacterial microbiota composition (Eppel et al. 2000; Worda et al. 2005; 
Koskimaa et al. 2012; Park et al. 2012; Uribarren-Berrueta et al. 2012; Brotman et 
al. 2014; Steinau et al. 2014). Our study detected HPV in 23% of the cervical 
samples, which is in line with the previous studies (Eppel et al. 2000; Koskimaa et 
al. 2012; Park et al. 2012).  
HPV infection has been linked to higher richness and diversity of bacterial 
microbiota in the cervix in pregnant and non-pregnant females (da Silva et al. 2004; 
Gao et al. 2013; Lee et al. 2013a; Mitra et al. 2015b, 2016; Dareng et al. 2016; Kero 
et al. 2017; Shannon et al. 2017). Moreover, higher bacterial diversity increases the 
risk of bacterial dysbiosis and bacterial vaginosis (Van De Wijgert et al. 2014; Mitra 
et al. 2015a). On the other hand, it has been shown, that bacterial vaginosis and high 
bacterial diversity and richness may predict HPV persistence and even carcinoma 
development (Mitra et al. 2015a; Kero et al. 2017). In our samples with pregnant 
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women, however, no differences in bacterial richness or diversity were seen 
according to HPV status. Probably due to limited number of samples we were unable 
to reach statistical significance in the bacterial richness or diversity measures. It is 
still not completely clear how the bacterial microbiota interacts with HPV and what 
impact microbiota may have in persistent HPV infection in cervical region (Mitra et 
al. 2016).  
Oral and cervical samples were collected by a similar method, by a brush. Our 
results showed higher amounts of bacterial DNA detected in the cervical samples 
(average 89.773 reads, range from 34.955 to 138.263 reads) than in the oral cavity 
samples (average 76.184, range from 32.373 to 128 565 reads). Similar bacterial 
levels in the uterine cervix have been detected in a recent study when samples were 
collected with cytobrush as in our study (Mitra et al. 2017). This might be 
considered surprising, since the oral cavity is known to be a rich source of bacteria 
(Figure 5) (Dewhirst et al. 2010). It is known that differences in the methodology 
in DNA extraction process can influence the total number of DNA sequences, but 
not the microbiota detected (Rosenbaum et al. 2019). The brush method may 
collect more bacterial DNA in the vaginal region but perhaps more human DNA 
in the oral cavity. Furthermore, in adults, there are normally occurring variations 
in the bacterial counts in the oral cavity considering the anatomical areas, as well 
as eating, tooth brushing, sampling method and testing time can influence the 
results as well (Ghasemi, Mazaheri and Tahmourespour 2017; Coelho et al. 2018; 
Iwawaki et al. 2019).  
The original Finnish Family HPV Study was designed to evaluate HPV 
interactions between family members. The sample collection was designed and 
performed without plans for microbiome studies. Therefore, no restrictions were 
given to the patients before the sample collection. This may at some extent affect our 
study results. The hormonal changes associated with pregnancy might have affected 
the collected bacterial DNA load in this study. In line with this notion, lower levels 
of bacteria have been detected from pregnant compared to non-pregnant women 
(Freitas et al. 2017). Furthermore, the brush only collects surface epithelial cells and 
bacteria from the mucosal surfaces. Oral bacteria often form complex biofilms which 
helps bacteria to attach to surfaces and helps bacteria protect against antimicrobial 
agents. The dental plaque or biofilm from deeper dental periodontal pocket may not 
have been included in the oral samples obtained with the brush method. Different 
methods in sample collection might have altered our results.  
In addition, the cervical brush samples were collected into tubes with buffer 
solution with small amount of gentamycin. Gentamycin is an antibiotic used to treat 
several different types of bacterial infections in humans. In research purposes, it is 
often used in cervical sample collection to prevent undesirable bacterial 
contamination that can occur during sample transportation and storage. Furthermore, 
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as the original study focused on HPV and on other viruses, gentamycin was not 
thought to be harmful for the analyses.  
Altogether 33% of the placenta samples in this study were positive for HPV. 
HPV has previously been detected in healthy pregnancies, and, in line with this 
observation, the pregnancies in our study did not have any adverse complications 
(Sarkola et al. 2008a; Skoczyński, Goździcka-Józefiak and Kwaśniewska 2011; Park 
et al. 2012; Lee et al. 2013b; Kim et al. 2014). However, there have been some 
indications that HPV placenta might increase the risk for premature delivery and 
other pregnancy complications (Gomez et al. 2008; Hong, Oshiro and Chan 2013; 
Slatter et al. 2015; Ambühl et al. 2016; Bober et al. 2019; Caballero et al. 2019). In 
order to distinguish true HPV infection from contamination, mainly from the birth 
canal, one study obtained placenta samples transabdominally and were still able to 
detect HPV DNA (Weyn et al. 2011). Results of the Finnish Family HPV Study, 
have shown with tyramide amplified in situ hybridisation that the HPV locates inside 
the syncytiotrophoblast cells (Sarkola et al. 2008a). HPV DNA localization in 
syncytiotrophoblast cells has subsequently been corroborated in other studies (You 
et al. 2008; Bober et al. 2019).  
The possible presence of bacteria in the placenta has been a focus of intensive 
research in recent years and arguments for and against have been made (Aagaard et 
al. 2014; Wassenaar and Panigrahi 2014; Collado et al. 2016; Lauder et al. 2016; 
Doyle et al. 2017; Parnell et al. 2017; Pelzer et al. 2017; Perez-Muñoz et al. 2017; 
Zheng et al. 2017a, 2017b). For decades it has been thought that the foetus develops 
in a sterile environment and first encounters bacteria in birth canal and after the 
delivery. Germ free animals are known to be bread successfully and the off-springs 
are germ-free as well after the delivery (Arvidsson, Hallén and Bäckhed 2012). 
Many of the studies claiming that there are no bacterial traces in the placenta samples 
have declared that the bacteria detected are a result of contamination either from the 
analysing kits or from the laboratory (Lauder et al. 2016; Perez-Muñoz et al. 2017; 
Leiby et al. 2018; de Goffau et al. 2019; Theis et al. 2019).   
Nevertheless, several studies have been able to detect bacterial DNA traces in 
placenta samples with different methodology (16S rRNA gene sequencing, WGS, 
culture and staining with microscopy), showing placenta mainly harbouring 
Proteobacteria, Prevotella, Streptococcus and Veillonella regardless of delivery 
mode (Satokari et al. 2009; Rautava et al. 2012b; Stout et al. 2013; Aagaard et al. 
2014; Cao and Mysorekar 2014; Wassenaar and Panigrahi 2014; Zheng et al. 2015; 
Collado et al. 2016; Zheng et al. 2017b, 2017a; Gomez-Arango et al. 2017a; Parnell 
et al. 2017; Benny et al. 2019). Furthermore, differences in the analysed placenta 
microbiota have been seen in samples obtained from term/preterm deliveries, from 
mothers with gestational diabetes or excess weight gain during pregnancy or in cases 
of pre-eclampsia and chorioamnionitis when compared to healthy delivered placenta 
Discussion 
 69 
samples (Queiros da Mota et al. 2013; Amarasekara et al. 2015; Antony et al. 2015; 
Bassols et al. 2016; Lloyd-Price, Abu-Ali and Huttenhower 2016; Zheng et al. 
2017b; Doyle et al. 2017; Pelzer et al. 2017; Zheng et al. 2017a; Benny et al. 2019; 
Younge et al. 2019). In addition, in our study we detected significant differences in 
the bacteria detected in the placenta samples according to HPV status. Bacterial 
composition has also been detected to vary within different sites of placenta (Parnell 
2017). There are slowly accumulating data that may interpreted to confirm the novel 
concept of true microbial colonization in the placenta but this still controversial 
subject warrants further research for the scientific community to have mutual 
agreement over the subject.  
One of the main findings in our studies was that we were able to detect bacterial 
DNA from our placental samples, there were no differences in the placenta samples 
according to delivery mode at family or genus levels. Our samples create a 
completely new placenta dataset, which has previously not been investigated by 
any of the bacterial detection methods. The bacteria we detected in the placenta 
were mainly members off Firmicutes, Proteobacteria, Actinobacteria and 
Bacteroidetes, which is in line with earlier studies that have been able to detect 
bacteria in placenta samples (Aagaard et al. 2014; Collado et al. 2016; Doyle et al. 
2017; Parnell et al. 2017; Pelzer et al. 2017; Zheng et al. 2017a, 2017b; Benny et 
al. 2019).  
Even though the research evidence of bacteria in the placenta has been 
increasing, the topic has created discussion and debate. The dogma of a sterile uterus 
has prevailed for decades and therefore this novel finding is challenging previous 
perceptions. The main problem in bacteria identification has been the small number 
of detectable bacterial DNA traces (Hornef and Penders 2017; Perez-Muñoz et al. 
2017). In our study, we worked carefully to exclude possible contaminants and 
excluded some placenta samples from microbiota analyses, because of low number 
of sequences. The amount of bacterial DNA sequences in some of the placenta 
samples were relatively small (starting from 100 sequences), but we did have number 
of samples with very high DNA sequences (up to 20.000 sequences). In addition, our 
placenta samples presented clearly higher number of reads than our negative controls 
(Figure 12). Nonetheless, when it comes to birth, sample selection is always at risk 
of contamination.   
In addition to the presence of bacterial DNA in the placenta, we detected 
differences in microbiota composition according to the HPV status of the samples. 
In HPV positive placenta samples, we detected significantly higher amounts of 
Ureaplasma and Lactobacillaceae when compared to HPV negative placenta 
samples. Ureaplasma has previously been connected with pregnancy complications, 
as it seems to associate with chorioamnionitis and preterm delivery (Sweeney et al. 
2012, 2016, 2017; Cox et al. 2016; Doyle et al. 2017; Kikhney et al. 2017). The 
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reason for this was not in the scope of this study and should be evaluated with further 
studies. All of the pregnancies in our study were carried out without any adverse 
effects, even the ones with HPV positive placenta and/or cervix.  
The placental microbiota has previously been detected to be significantly 
different in mothers suffering from gestational diabetes (Zheng et al. 2017b) or 
delivering preterm (Antony et al. 2015; Prince et al. 2016). To the author’s best 
knowledge, this work is the first to describe the differences in the bacteria detected 
in placenta in association with the HPV status. We interpret our findings to 
strengthen the novel idea of a true bacterial colonization in the placenta. Further 
studies are necessary to truly understand the role of bacterial colonization in the 
placenta and the viral-bacterial interactions.  
We further on studied the microbiota composition in breast milk. The milk 
microbiota included mainly Streptococcaceae, Staphylococcaceae and 
Proteobacteria which is in line with other studies, while some geographical 
differences have been reported to occur (Martín et al. 2007; Jeurink et al. 2013; 
Urbaniak et al. 2014; Aakko et al. 2017; Biagi et al. 2017; Cacho et al. 2017; Li et 
al. 2017b). HPV has additionally been previously detected in breast milk and it is 
thought to derive from epithelial cell shedding from the ductal canal or from the 
nipple epidermis, since HPV requires epithelial cell differentiation for its cell cycle 
(Cazzaniga et al. 2009; Diaz et al. 2018). In addition, HPV has been detected from 
normal breast tissue (without lactating) and from breast tumour specimens (de 
Villiers et al. 2005; Heng et al. 2009).  
Both mucosal and cutaneous HPV genotypes have been detected in milk 
(Cazzaniga et al. 2009). In general, HPV positivity has shifted between 1.4% - 28.8% 
in different studies investigating the HPV presence in breast milk (Sarkola et al. 
2008b; Cazzaniga et al. 2009; Yoshida et al. 2011; Glenn, Whitaker and Lawson 
2012; Louvanto et al. 2017; Diaz et al. 2018). Contradictory, some investigators 
have not detected any HR-HPVs in breast milk samples (Mammas et al. 2011). In 
our samples, three breast milk samples were positive for HPV; only one with HR-
HPV16 and two others to LR-HPV6. Since the study referred here did not take into 
account the LR-HPV, they would probably have missed a number of potentially 
positive samples.   
Because only three HPV positive breast milk samples were detected in our study 
samples no statistical microbiota analyses were performed. Previously, we have 
shown in the Finnish Family HPV Study (Louvanto et al. 2017) that HPV in breast 
milk could be a risk factor for the spouse to acquire oral HPV infection but 
transmission of HPV infection to the infant mouth by breast milk positive for HPV 
has not been observed (Sarkola et al. 2008b; Yoshida et al. 2011; Louvanto et al. 
2017). In our study population, all of the infants received breast milk as their primary 
food source. 
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6.2 HPV and microbiota interactions in infants 
 We detected oral HPV infection in 40% of infants, which is somewhat higher than 
in previous studies, in which oral HPV has been discovered in 3.2% -21% of infants 
(Rintala et al. 2005a; Park et al. 2012; Hahn et al. 2013; Hong et al. 2013; Trottier 
et al. 2016). Our subset population of the Finnish Family HPV Study presented 
significantly higher levels of HPV DNA in the infant oral cavity, than the entire 
Finnish Family HPV Study infant population (40% to 10%, respectively) (Rintala et 
al. 2005a). The amount of HPV DNA positive placental samples, which originally 
identified our sample selection, could have had an impact to our infant data and may 
distort the results. 
Infants may acquire HPV infection by vertical transmission from the mother 
prenatally via the placenta or during vaginal delivery or from the mother or the father 
during caregiving (Syrjänen and Puranen 2000; Rintala et al. 2005a, 2005b; 
Koskimaa et al. 2012; Park et al. 2012; Lee et al. 2013b; Merckx et al. 2013; 
Chatzistamatiou, Sotiriadis and Agorastos 2016). HPV positive cord blood 
reportedly increases the infant’s risk of being HPV positive (Rombaldi et al. 2008; 
Sarkola et al. 2008a; Teixeira et al. 2015).  
We detected maturation of the infant oral microbiota from delivery to two 
months of age. The two-month-old infants had higher richness and Streptococcus, 
Veillonella and Rothia species were more abundant in the oral cavity compared to 
neonates. Our results are consistent with previous studies (Dominguez-Bello et al. 
2010; Lif Holgerson et al. 2011; Rosenblatt et al. 2015; Chu et al. 2017; Li et al. 
2018). Firmicutes, Streptococcus and Veillonella are showed to form the core of 
infant oral cavity microbiota (Biagi et al. 2017; Drell et al. 2017; Dzidic et al. 
2018b). It is of note that neonates are born without teeth and there are only mucosal 
surfaces in the oral cavity to harbour the microbiota. During the first year of life, the 
teeth start to erupt and that markedly affects to the microbiota composition with hard 
tissue surfaces to form biofilms (Caufield, Cutter and Dasanayake 1993; Sampaio-
Maia and Monteiro-Silva 2014). It is of note that under these drastic changes, the 
infant oral microbiota also changes in response to external and internal changes up 
until two years of age (Dzidic et al. 2018b). In contrast to previous studies 
(Dominguez-Bello et al. 2010; Lif Holgerson et al. 2011; Rosenblatt et al. 2015; Li 
et al. 2018), we did not detect any differences in the initial neonatal oral cavity 
bacterial microbiota compositions between infants born vaginally (60%, n=21/35) or 
by Caesarean section delivery (40%, n=14/35). 
We detected significant differences in the infant oral cavity microbiota according 
to HPV status. Veillonella and Veillonella dispar were more abundant in HPV 
negative infant oral cavity, while Propionibacterium and Ureaplasma were 
significantly enriched in HPV positive infant oral cavity. As far as we know, the 
connections with bacterial microbiota and HPV in neonates’ have not been studied 
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before. Higher levels of Propionibacterium have previously been connected to 
premature neonates’ gut microbiota and Ureaplasma has been detected in the uterine 
cervix in preterm births (Aujoulat et al. 2014; Doyle et al. 2017). There has not been 
any connection to HPV in these studies and no information about HPV and 
microbiota interactions in infants has been available before.  Given the possible role 
of HPV infection in pregnancy complications, discussed above, the interaction 
between HPV and the bacterial microbiota in the pathogenesis of preterm birth needs 
further study, since preterm birth may have significant clinical life-long effect to the 
children (Ruiz et al. 2016). It is of note, however, that none of the deliveries in the 
present study occurred significantly preterm, as even the shortest pregnancy lasted 
until 35 weeks.  
Understanding oral microbiota development in early life is important since the 
initial oral cavity microbiota during the first year of life has been reported to be 
associated with children’s oral and overall health later in life (Dzidic et al. 2018b, 
2018a). We investigated the impact of the maternal microbiota to the neonatal oral 
cavity bacterial microbiota composition. A significant contribution of the bacteria 
detected in the placenta seemed to contribute significantly to initial neonatal oral 
colonisation. The samples in our study were collected directly after delivery before 
any other contact to mother or feeding. A number of different analyses (PCoA, 
Network and SourceTracker) all gave similar results indicating that the placenta may 
primarily contribute to the early neonatal oral microbiota. Furthermore, our analyses 
connected an individual neonate’s oral bacteria to his own mother’s bacteria detected 
from the placenta more (p=0.075) than to the own mother’s oral cavity (p=0.83) or 
to the cervical microbiota (p=0.79). The impact of bacteria from the placenta to the 
developing neonatal oral microbiota has not been studied extensively, but one recent 
report corroborated our findings and revealed connections between the placenta and 
neonatal oral cavity microbiota (Younge et al. 2019). Furthermore, in the present 
study, individual mother-neonate pairs resembled more closely each other than 
unrelated mothers and neonates. Of the 16 individual bacterial genera detected in 
placenta, 12 genera were in addition present in neonatal oral cavity. All of these 
findings suggest that neonatal oral cavity might have a prenatal exposure to bacteria 
before the moment of delivery. Furthermore, we did not observe differences in the 
neonatal oral bacterial microbiota composition according to delivery mode.  
It also seems that HPV infection in the infant oral cavity is a relatively common 
finding and has an association with the bacterial microbiota composition. 
Importantly, present HPV infection appears to be connected with well-known 
pathogens. It is known that infant oral microbiota gradually matures within months 
and years. Therefore, whether these initial changes observed in infant oral cavity 
bacterial microbiota composition according to HPV status have an impact to oral 
health later in life remains to be elucidated in future studies.   
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Our study is observational, and it is therefore not clear whether the bacterial 
microbiota alterations and presence of potentially pathogenic bacteria might 
facilitate HPV transmission or if HPV infection induces these changes in microbiota 
composition. Furthermore, it is not known how these viral –bacterial interactions 
might affect HPV persistence and thus further studies are warranted.  
6.3 In vitro studies 
Chronic infection and inflammation, whether derived from bacterial or viral (HPV) 
infection, may lead to cancer development (Coussens and Werb 2002; Murata 2018). 
One of the most studied entities in this respect is the role of persistent HPV infection 
in CSCC and HNSCC development (Schneider and Koutsky 1992; Syrjänen 2005; 
zur Hausen 2009; Stanley 2010; Louvanto et al. 2011b; Rintala et al. 2012; Gillison 
et al. 2014). We show here, that HPV positive CSCC lines (SiHa and CaSki) are able 
to invade to both solid (Myoma) and gelatinous (Myogel) human uterine leiomyoma-
based extracellular matrix models. Previously, these models have mainly been 
studied using the aggressive oral tongue squamous cell carcinoma line, HSC-3 
(Teppo et al. 2013; Kauppila et al. 2015; Pirilä et al. 2015; Salo et al. 2015, 2018; 
Mäkinen et al. 2016; Sundquist et al. 2016; Al-Samadi et al. 2017; Korvala et al. 
2017; Väyrynen et al. 2018, 2019). 
HPV positive cells were cultivable in Myogel cultures and were able to invade 
into the prepared Myogel extracellular matrix gel. No information about HPV 
positive cells behaviour in Myogel has been presented before. Our results show that, 
SiHa and CaSki cells survive and invade to the Myogel equally. No statistically 
significant differences were observed between the different cell lines in the Myogel 
Transwell invasion assay. 
The myoma model has been designed for invasion assays as the matrix is of 
entirely human origin and closely mimics the tumour microenvironment of solid 
cancers (Teppo et al. 2013; Alahuhta et al. 2015; Sundquist et al. 2016; Salo et al. 
2018). We observed HPV copy number to be potentially associated with slight 
differences in invasion to myoma, as SiHa (less HPV) invaded clearly more 
aggressively than CaSki (more HPV). Nonetheless, no differences were observed in 
the invasion area, and the detected differences could therefore be explained by the 
normally occurring differences between the different cell lines. Differences in 
invasion depth and invasion area may also be explained by different invasion 
patterns of cellular level; SiHa invaded to the tissue with single cells or tiny cell 
islands (small buds), whereas CaSki invaded in bigger droplets.  
Furthermore, we wanted to investigate whether ionized radiation has an impact 
on cell invasion. HPV positive HNSCC, OPSCC and CSCC patients have been 
observed to be more radiosensitive than HPV negative carcinomas (Bachtiary et al. 
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2002; Harima et al. 2002; Ang et al. 2010; Kimple et al. 2013; Zhang et al. 2015; Li 
et al. 2017a; Ibragimova et al. 2018). HPV negative CSCC has been shown to have 
greater potential to metastasise, which could explain the poorer prognosis (Riou et 
al. 1990; Crook and Vousden 1992; Li et al. 2017a).  
Previous studies have shown, that irradiation at 4 Gy significantly decreases cell 
invasion (Väyrynen et al. 2018). Our results are consistent with this notion, as both 
SiHa and CaSki showed statistically significant decrease in cell invasion depth after 
irradiation. However, no differences were seen in the invasion area, even though a 
decrease in numbers was evident and a dramatic drop in the invasion indexes was 
seen. The invasion depth decreased more in SiHa (less HPV) than in CaSki (more 
HPV) cells and significant difference (p=0.048) between HPV negative cell and 
HPV positive cell invasion after ionized radiation was observed. This indicates that 
HPV infection affects radiosensitivity in these cell lines despite the fact that that no 
similar difference in the invasion area (p=0.892) was observed. Our results suggest 
that ionized radiation impacts overall to cell invasion depth and area even regardless 
of the HPV status by decreasing the invasive potential of carcinoma cells even after 
relatively low and only single dose of irradiation. 
6.4 Limitations and strengths 
There are limitations to this study. First, the relatively small sample size potentially 
restricts us from detecting significant differences and making definitive conclusions 
from this study. More than 300 families participated in the original Finnish Family 
HPV Study. Only 13 women had HPV positive placentas which restricted our final 
study group in studies I-III. Furthermore, a number of placenta samples, those that 
had less than 1000 reads per sample, were excluded from the study I, to strengthen 
the results. In addition, the relatively low number of usable DNA residues from 
bacteria in placenta samples renders drawing definitive conclusions of the overall 
composition of microbiota difficult.    
Secondly, the small amount of detectable bacterial DNA in both placental and 
neonatal oral cavity might have some impact on our results. We have used the same 
methods for collecting oral samples with cytobrush and placenta biopsy samples for 
bacterial DNA analyses that have previously been used, which therefore should not 
explain this difference (Rombaldi et al. 2008; Lee et al. 2013b; Antony et al. 2015; 
Mitra et al. 2017; Rosenbaum et al. 2019). We would speculate, that sample 
collection from neonate’s oral cavity may have been performed slightly too gently 
compared to adults.  
However, since our study was cross-sectional, we cannot evaluate the causal 
relationships of HPV and bacterial microbiota interactions. The question whether 
HPV infection leads to the observed changes in the bacterial microbiota composition 
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in the mother oral cavity, the cervix, the placenta and in the neonatal oral cavity or 
whether certain type of microbiota profile predisposes to HPV remains to be 
determined in future studies.  
Thirdly, cell cultivation with HPV positive cell lines is somewhat technique 
sensitive and naturally occurring differences in the behaviour of different cell lines 
makes it difficult to compare their behaviour in vitro. Furthermore, in these in vitro 
studies we utilized HPV positive CSCC cell lines and compared the results with HPV 
negative OPSCC cell line. Since several underlying factors contribute to carcinoma 
cell behaviour, is must be addressed that our results might have been somewhat 
different had we used carcinoma cell lines from the same anatomical site.  
Regardless of these limitations, we have presented evidence for traces of 
bacterial DNA detected in the placenta samples. We have used the same bacterial 
DNA method with all of our samples and sequenced the V3-V4 region of the 16S 
rRNA gene in order to have comparable results. A strict protocol was followed while 
working with the low DNA quantities obtained from the placenta and infant oral 
samples, and we included the same strict protocol with PCR amplifications and 
library kit controls. Before analysing the generated microbiota data, it was cleared 
from possible contaminants as singletons and OTU’s with relative frequency below 
0.01 were removed. Furthermore, sequences that could not be classified to domain 
level were removed. Similarly, Cyanobacteria, Chloroplasts and Rhizobiales as 
potential environmental contaminants were removed before the microbiota analyses. 
In addition, we were able to detect differences in the microbiota composition 
according to HPV status in placenta, mother and infant oral cavity and in cervical 
samples. These findings corroborate the recently presented novel discovery that the 
placenta might harbour a specific bacterial microbiota and the foetus might not 
develop in a sterile environment (Aagaard et al. 2014; Collado et al. 2016).  
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7 Conclusions 
The main conclusions of the present study were: 
1. The oral cavity of pregnant women and their infants as well as the cervix, 
placenta and breast milk all harbour a unique and distinct microbiota profile. 
Two-month-old infants’ oral microbiota have higher bacterial richness than 
new-borns oral cavity microbiota. The placental and neonatal oral cavity 
samples present lower amounts of detectable bacterial DNA than maternal oral 
cavity, cervix and breast milk. 
2. HPV infection is associated with distinct bacterial microbiota in the maternal 
and infant mouth, uterine cervix and placenta. In particular, potentially 
pathogenic bacteria are detected to be more abundant in HPV positive 
samples, such as Selenomonas in the maternal oral cavity, Atopobium vaginae 
in the cervix, as well as Ureaplasma in the placenta and in the infant oral 
cavity.  
3. The initial neonatal oral microbiota shares features mainly with the microbial 
profile in the placenta. This observation was consistently made using various 
analysis methods and the microbiota seems not to be strongly modulated by 
the birth canal microbiota regardless of the mode of delivery.  
4. Both human uterine leiomyoma–based extracellular matrix models, myoma 
and Myogel, are excellent platforms in investigating the cell invasion with 
HPV positive cell lines. No differences in the behaviour of the cells, between 
HPV positive and negative cell lines are apparent in myoma model or in 
Myogel. Furthermore, there are no drastic differences between SiHa and 
CaSki, in which the number of viral copies in the genome differ quite 
dramatically. Ionized radiation results in similar outcomes in all cell lines, as 
the invasion depth is significantly reduced in all cell lines. We conclude that 
irradiation affects cells despite the HPV status. 
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